PRKAA2 encodes the alpha-2 catalytic subunit of AMP-activated protein kinase (AMPK), a central cellular energy sensor that maintains energy homeostasis. As a serine/threonine kinase, PRKAA2 is activated when cellular AMP/ATP ratios rise, triggering phosphorylation of metabolic enzymes to suppress anabolic processes (fatty acid/cholesterol synthesis) while promoting catabolic processes (fatty acid oxidation, glycolysis, autophagy). The protein forms heterotrimeric complexes with regulatory beta and gamma subunits, localizes to both cytoplasm and nucleus, and phosphorylates key substrates including ACC (fatty acid synthesis), HMGCR (cholesterol synthesis), PFK-2 (glycolysis), and ChREBP (transcriptional regulation). Recent discoveries highlight its direct role in chromatin remodeling via histone H2B phosphorylation under stress conditions.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004674
protein serine/threonine kinase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core catalytic function strongly supported by extensive biochemical evidence. PRKAA2 phosphorylates serine/threonine residues on numerous substrates (ACC, HMGCR, PFK-2, ChREBP, TSC2, Raptor). Multiple IDA studies confirm this activity (PMID:8955377, PMID:12065578).
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research.md
Generated using OpenAI Deep Research API
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
Prkaa2 encodes a **protein kinase** (EC 2.7.11.1; Ser/Thr kinase).
|
|
GO:0010508
positive regulation of autophagy
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Well-established function through ULK1 phosphorylation and mTORC1 inhibition. However, 2024 research shows complexity - AMPK can suppress autophagy in specific contexts. Keep as important but context-dependent function.
|
|
GO:0042149
cellular response to glucose starvation
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core function - AMPK is the primary cellular glucose/energy sensor. Activated by low glucose via AMP/ATP ratio changes. Knockout mice show impaired glucose homeostasis. Multiple ISS/ISO annotations support this.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation.
|
|
GO:0006338
chromatin remodeling
|
IEA
GO_REF:0000108 |
ACCEPT |
Summary: Supported by evidence that AMPK/PRKAA2 phosphorylates histone H2B under metabolic stress, linking energy sensing to chromatin remodeling.
Reason: Chromatin remodeling is supported by histone H2B Ser36 phosphorylation in stress conditions, aligning with core_functions that capture this epigenetic regulation.
|
|
GO:0004672
protein kinase activity
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: Too general - more specific terms available (serine/threonine kinase, AMP-activated protein kinase). Redundant with better-annotated specific terms.
|
|
GO:0004679
AMP-activated protein kinase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Core defining function of PRKAA2. Multiple IDA studies confirm (PMID:11069105, PMID:11724780, PMID:14511394). This is THE primary molecular function.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation.
|
|
GO:0005524
ATP binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Essential for kinase function - ATP is the phosphate donor. IDA evidence exists (PMID:16648175). Crystal structures confirm ATP-binding pocket.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
The α subunit provides the **catalytic kinase activity** and is activated primarily by phosphorylation at a conserved threonine within the activation loop (**Thr172 for α2**), which is a core mechanistic definition of “AMPK activation.”
|
|
GO:0000166
nucleotide binding
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too general - ATP binding is more specific and already annotated. Redundant.
|
|
GO:0004674
protein serine/threonine kinase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated annotation consistent with IBA and IDA evidence. Core kinase function.
|
|
GO:0006325
chromatin organization
|
IEA
GO_REF:0000043 |
MARK AS OVER ANNOTATED |
Summary: Weak IEA evidence. While H2B phosphorylation occurs, this is stress-specific and not a primary function. Too broad.
|
|
GO:0006629
lipid metabolic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Core function via ACC and HMGCR phosphorylation. Controls fatty acid and cholesterol synthesis. Strong experimental support (PMID:12065578). However, more specific terms available.
|
|
GO:0006631
fatty acid metabolic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Core function - directly regulates ACC to control fatty acid synthesis/oxidation balance. IDA evidence for fatty acid homeostasis (PMID:11724780).
|
|
GO:0006633
fatty acid biosynthetic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: AMPK actually INHIBITS fatty acid synthesis by phosphorylating ACC. This annotation implies positive regulation which is incorrect.
|
|
GO:0006694
steroid biosynthetic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too broad and AMPK generally inhibits steroid/cholesterol synthesis. More specific negative regulation terms would be appropriate.
|
|
GO:0006695
cholesterol biosynthetic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: AMPK INHIBITS cholesterol synthesis via HMGCR phosphorylation. This term implies positive regulation which is incorrect.
|
|
GO:0006914
autophagy
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too broad - 'positive regulation of autophagy' is more accurate. Complex bidirectional regulation discovered in 2024.
|
|
GO:0008202
steroid metabolic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too broad. AMPK's role is more specific to cholesterol metabolism inhibition.
|
|
GO:0008203
cholesterol metabolic process
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: AMPK regulates cholesterol metabolism primarily through HMGCR inhibition. Keep but note the regulatory direction.
Reason: PRKAA2 directly phosphorylates and inhibits HMGCR, making cholesterol metabolism a core regulated process in energy stress.
|
|
GO:0016055
Wnt signaling pathway
|
IEA
GO_REF:0000043 |
MARK AS OVER ANNOTATED |
Summary: Weak evidence, likely indirect effect. May phosphorylate beta-catenin but not a primary function. IEA only.
|
|
GO:0016126
sterol biosynthetic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: AMPK inhibits rather than promotes sterol synthesis. Misleading annotation.
|
|
GO:0016301
kinase activity
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too general - more specific terms (protein serine/threonine kinase, AMP-activated protein kinase) are already annotated.
|
|
GO:0016740
transferase activity
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Far too general - specific kinase terms already present. No value added.
|
|
GO:0031000
response to caffeine
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: IDA evidence exists (PMID:19608206) showing caffeine activates AMPK in muscle. However, this is a pharmacological response, not a core function.
|
|
GO:0045821
positive regulation of glycolytic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Core function - AMPK phosphorylates PFK-2 at Ser466 to activate glycolysis. Strong IDA evidence (PMID:11069105). Critical for ATP generation under stress.
|
|
GO:0046872
metal ion binding
|
IEA
GO_REF:0000043 |
MODIFY |
Summary: Mg2+ binding is required for kinase activity (coordinates ATP). Standard feature of protein kinases. Could be more specific.
Proposed replacements:
magnesium ion binding
|
|
GO:0047322
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Specific substrate phosphorylation well-documented (PMID:2369897). Important for cholesterol homeostasis. Keep as it provides mechanistic specificity.
|
|
GO:0048511
rhythmic process
|
IEA
GO_REF:0000043 |
REMOVE |
Summary: Too vague. 'Regulation of circadian rhythm' is more specific and has better evidence. Redundant.
|
|
GO:0055089
fatty acid homeostasis
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Core function with strong IDA evidence (PMID:11724780). AMPK balances fatty acid synthesis/oxidation via ACC phosphorylation.
|
|
GO:0071277
cellular response to calcium ion
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: AMPK is activated by CaMKK2 in response to calcium. IMP evidence exists (PMID:25788287). Important regulatory mechanism but not primary function.
|
|
GO:0071333
cellular response to glucose stimulus
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Core function - responds to both high and low glucose. IMP evidence (PMID:25788287). Central to glucose homeostasis.
|
|
GO:0097009
energy homeostasis
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: THE core function of AMPK - master regulator of cellular energy balance. Strong IDA evidence (PMID:11724780). Fundamental role.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
Functionally, AMPKα2 integrates energy stress to inhibit anabolic metabolism and promote catabolism and autophagy
|
|
GO:0106310
protein serine kinase activity
|
IEA
GO_REF:0000116 |
REMOVE |
Summary: Redundant with 'protein serine/threonine kinase activity' which is more complete and has better evidence.
|
|
GO:0031669
cellular response to nutrient levels
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Core function - AMPK senses and responds to nutrient availability. Strong ISO evidence from mouse. Fundamental role in metabolism. RETIRED - GO_REF:0000096 no longer used in GOA.
|
|
GO:0004679
AMP-activated protein kinase activity
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Duplicate annotation - core AMPK function already reviewed as IBA evidence type. This ISO annotation provides additional ortholog-based support for the same function. RETIRED - GO_REF:0000096 no longer used in GOA.
|
|
GO:0004674
protein serine/threonine kinase activity
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog-based annotation consistent with IBA and IDA evidence. Core kinase function. RETIRED - GO_REF:0000096 no longer used in GOA.
|
|
GO:0140823
histone H2BS36 kinase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Evidence for H2B Ser36 phosphorylation by AMPK under stress conditions is well-established in mammals. This is a specific stress-response function supported by experimental data.
|
|
GO:0140823
histone H2BS36 kinase activity
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog evidence for H2B Ser36 phosphorylation under stress conditions.
|
|
GO:0004679
AMP-activated protein kinase activity
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
ACCEPT |
Summary: Strong evidence - PMID:25788287 shows calcium-dependent AMPK activation in neurons. IMP evidence for core AMPK function.
Supporting Evidence:
PMID:25788287
Polarized activities of AMPK and BRSK in primary hippocampal neurons
|
|
GO:0042149
cellular response to glucose starvation
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence similarity evidence for glucose starvation response. Core AMPK function.
|
|
GO:0042149
cellular response to glucose starvation
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog evidence for glucose starvation response. Core AMPK function.
|
|
GO:1905691
lipid droplet disassembly
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: AMPK promotes lipolysis and lipid droplet breakdown via phosphorylation of lipases and metabolic enzymes. This is supported by evidence of AMPK activating lipid oxidation pathways.
|
|
GO:1905691
lipid droplet disassembly
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for AMPK role in lipid droplet breakdown.
|
|
GO:0062028
regulation of stress granule assembly
|
ISO
GO_REF:0000096 |
MARK AS OVER ANNOTATED |
Summary: AMPK responds to stress conditions and may influence stress granule formation, but evidence is indirect. Likely over-annotation as not a primary function.
|
|
GO:0010629
negative regulation of gene expression
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: AMPK negatively regulates lipogenic genes (ChREBP, SREBP) and anabolic gene programs. However, term is too broad - more specific terms would be better.
|
|
GO:0034599
cellular response to oxidative stress
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: AMPK is activated during oxidative stress and promotes protective responses including autophagy. This is a legitimate stress response function.
|
|
GO:0070507
regulation of microtubule cytoskeleton organization
|
ISO
GO_REF:0000096 |
MARK AS OVER ANNOTATED |
Summary: Weak evidence - AMPK may indirectly affect cytoskeleton but this is not a well-established primary function. Likely over-annotation.
|
|
GO:0071277
cellular response to calcium ion
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for calcium-dependent AMPK activation. Important regulatory mechanism.
|
|
GO:0071277
cellular response to calcium ion
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
KEEP AS NON CORE |
Summary: Strong evidence - PMID:25788287 demonstrates calcium-dependent AMPK activation via CaMKK2 pathway. Important regulatory mechanism but not core metabolic function.
Supporting Evidence:
PMID:25788287
2015 Mar 18. Polarized activities of AMPK and BRSK in primary hippocampal neurons.
|
|
GO:0071333
cellular response to glucose stimulus
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog evidence for glucose response. Core AMPK function.
|
|
GO:0071333
cellular response to glucose stimulus
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
ACCEPT |
Summary: Strong supporting evidence for core glucose sensing function. IMP evidence adds to already accepted IEA annotation.
Supporting Evidence:
PMID:25788287
Polarized activities of AMPK and BRSK in primary hippocampal neurons
|
|
GO:0010468
regulation of gene expression
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Too broad - AMPK regulates specific gene sets via ChREBP, SREBP, p53, etc. More specific terms would be preferable.
|
|
GO:0014850
response to muscle activity
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Well-established function - AMPK is activated during muscle contraction and exercise. Important for muscle energy metabolism adaptation.
|
|
GO:0071466
cellular response to xenobiotic stimulus
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: AMPK can be activated by xenobiotics like AICAR, metformin, and other compounds. Secondary response, not core function.
|
|
GO:0016241
regulation of macroautophagy
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: More specific than general autophagy term. AMPK regulates macroautophagy via ULK1 phosphorylation and mTORC1 inhibition. Established function.
|
|
GO:0016241
regulation of macroautophagy
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for macroautophagy regulation. Established function.
|
|
GO:0071380
cellular response to prostaglandin E stimulus
|
ISO
GO_REF:0000096 |
MARK AS OVER ANNOTATED |
Summary: Very specific response that may occur but is not well-documented as primary function. Likely over-annotation.
|
|
GO:0004712
protein serine/threonine/tyrosine kinase activity
|
ISO
GO_REF:0000096 |
REMOVE |
Summary: AMPK is primarily serine/threonine kinase, not tyrosine. This broader term is less accurate than the specific serine/threonine kinase annotation.
|
|
GO:0003682
chromatin binding
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: AMPK translocates to nucleus under stress and binds chromatin to phosphorylate histones. Evidence from H2B phosphorylation studies supports this.
|
|
GO:0003682
chromatin binding
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for chromatin binding during stress responses.
|
|
GO:0004679
AMP-activated protein kinase activity
|
IDA
PMID:11069105 Phosphorylation and activation of heart PFK-2 by AMPK has a ... |
ACCEPT |
Summary: Strong direct evidence for core AMPK function. PMID:11069105 demonstrates AMPK phosphorylation of PFK-2, confirming kinase activity.
Supporting Evidence:
PMID:11069105
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
|
|
GO:0004679
AMP-activated protein kinase activity
|
IDA
PMID:11724780 Mechanism for fatty acid "sparing" effect on glucose-induced... |
ACCEPT |
Summary: Strong direct evidence for core AMPK function. PMID:11724780 demonstrates AMPK phosphorylation of ChREBP, confirming kinase activity.
Supporting Evidence:
PMID:11724780
Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase
|
|
GO:0005515
protein binding
|
IPI
PMID:11069105 Phosphorylation and activation of heart PFK-2 by AMPK has a ... |
REMOVE |
Summary: Too general - AMPK binds many proteins but more specific terms would be better (complex binding, substrate binding). Remove as uninformative.
Supporting Evidence:
PMID:11069105
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.
|
|
GO:0005515
protein binding
|
IPI
PMID:11724780 Mechanism for fatty acid "sparing" effect on glucose-induced... |
REMOVE |
Summary: Too general - AMPK binds many proteins but more specific terms would be better. Remove as uninformative.
Supporting Evidence:
PMID:11724780
Nov 27. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.
|
|
GO:0008610
lipid biosynthetic process
|
ISS
GO_REF:0000024 |
REMOVE |
Summary: Misleading - AMPK actually INHIBITS lipid biosynthesis by phosphorylating ACC and other enzymes. This should be negative regulation.
|
|
GO:0008610
lipid biosynthetic process
|
ISO
GO_REF:0000096 |
REMOVE |
Summary: Misleading - AMPK actually INHIBITS lipid biosynthesis. Remove incorrect annotation.
|
|
GO:0010508
positive regulation of autophagy
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence similarity evidence for autophagy regulation. Complex context-dependent function.
|
|
GO:0010508
positive regulation of autophagy
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for autophagy regulation. Complex context-dependent function.
|
|
GO:0031669
cellular response to nutrient levels
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence similarity evidence for nutrient sensing. Core AMPK function.
|
|
GO:0032007
negative regulation of TOR signaling
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Core function - AMPK inhibits mTORC1 via TSC2 and Raptor phosphorylation. Well-established mechanism for energy conservation.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
|
|
GO:0032007
negative regulation of TOR signaling
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog evidence for TOR inhibition. Core metabolic regulation.
|
|
GO:0042752
regulation of circadian rhythm
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: AMPK phosphorylates CRY1 and links metabolism to circadian rhythms. However, this is not a primary metabolic function.
|
|
GO:0042752
regulation of circadian rhythm
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for circadian regulation via CRY1 phosphorylation.
|
|
GO:0043066
negative regulation of apoptotic process
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: AMPK can promote cell survival during mild stress via autophagy and p53 phosphorylation. Context-dependent protective function.
|
|
GO:0043066
negative regulation of apoptotic process
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: Ortholog evidence for cell survival promotion during stress.
|
|
GO:0045821
positive regulation of glycolytic process
|
IDA
PMID:11069105 Phosphorylation and activation of heart PFK-2 by AMPK has a ... |
ACCEPT |
Summary: Strong direct evidence - PMID:11069105 demonstrates AMPK phosphorylation of PFK-2 which activates glycolysis. Core metabolic function.
Supporting Evidence:
PMID:11069105
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
|
|
GO:0055089
fatty acid homeostasis
|
IDA
PMID:11724780 Mechanism for fatty acid "sparing" effect on glucose-induced... |
ACCEPT |
Summary: Strong direct evidence - PMID:11724780 shows AMPK regulation of fatty acid metabolism via ACC phosphorylation. Core function already accepted from IEA.
Supporting Evidence:
PMID:11724780
Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase
|
|
GO:0097009
energy homeostasis
|
IDA
PMID:11724780 Mechanism for fatty acid "sparing" effect on glucose-induced... |
ACCEPT |
Summary: Strong direct evidence - PMID:11724780 demonstrates AMPK role in cellular energy balance. THE core function already accepted from IEA.
Supporting Evidence:
PMID:11724780
Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase
|
|
GO:0042593
glucose homeostasis
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Core function - AMPK is central to glucose homeostasis through multiple mechanisms. Well-established role in glucose metabolism.
|
|
GO:0042593
glucose homeostasis
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: Ortholog evidence for glucose homeostasis. Core metabolic function.
|
|
GO:0014823
response to activity
|
IDA
PMID:17253964 Adrenaline is a critical mediator of acute exercise-induced ... |
KEEP AS NON CORE |
Summary: PMID:17253964 shows adrenergic activation of AMPK in adipocytes during activity. Important physiological response but not core function.
Supporting Evidence:
PMID:17253964
Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes.
|
|
GO:0031000
response to caffeine
|
IDA
PMID:19608206 Caffeine acutely activates 5'adenosine monophosphate-activat... |
KEEP AS NON CORE |
Summary: Strong direct evidence - PMID:19608206 shows caffeine activates AMPK in skeletal muscle. Pharmacological response already accepted from IEA.
Supporting Evidence:
PMID:19608206
2009 Jul 15. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles.
|
|
GO:0004679
AMP-activated protein kinase activity
|
IDA
PMID:14511394 Complexes between the LKB1 tumor suppressor, STRAD alpha/bet... |
ACCEPT |
Summary: Strong direct evidence - PMID:14511394 demonstrates AMPK complexes and upstream kinase LKB1. Direct confirmation of kinase activity.
Supporting Evidence:
PMID:14511394
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade
|
|
GO:0044877
protein-containing complex binding
|
IDA
PMID:14511394 Complexes between the LKB1 tumor suppressor, STRAD alpha/bet... |
KEEP AS NON CORE |
Summary: PMID:14511394 shows AMPK interaction with LKB1-STRD-MO25 complex. Specific complex binding is more informative than general protein binding.
Supporting Evidence:
PMID:14511394
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
|
|
GO:0004674
protein serine/threonine kinase activity
|
IDA
PMID:8955377 The alpha1 and alpha2 isoforms of the AMP-activated protein ... |
ACCEPT |
Summary: Strong direct evidence - PMID:8955377 demonstrates substrate specificity differences between α1 and α2 isoforms. Core kinase function.
Supporting Evidence:
PMID:8955377
The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro.
|
|
GO:0004679
AMP-activated protein kinase activity
|
IMP
PMID:10698692 Characterization of AMP-activated protein kinase gamma-subun... |
ACCEPT |
Summary: IMP evidence from γ subunit characterization study. Shows requirement for γ subunit in AMP binding and AMPK activation.
Supporting Evidence:
PMID:10698692
Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding
|
|
GO:0004679
AMP-activated protein kinase activity
|
IMP
PMID:8955377 The alpha1 and alpha2 isoforms of the AMP-activated protein ... |
ACCEPT |
Summary: IMP evidence showing differential properties of α2 vs α1 complexes. Demonstrates AMP-activation specifically.
Supporting Evidence:
PMID:8955377
The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro.
|
|
GO:0030674
protein-macromolecule adaptor activity
|
IDA
PMID:15695819 AMP-activated protein kinase beta subunit tethers alpha and ... |
REMOVE |
Summary: PMID:15695819 shows β subunit tethering α and γ subunits. However, this refers to β subunit function, not α2 directly.
Supporting Evidence:
PMID:15695819
2005 Jan 28. AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270).
|
|
GO:0004679
AMP-activated protein kinase activity
|
IDA
PMID:16648175 Activation of AMPK alpha- and gamma-isoform complexes in the... |
ACCEPT |
Summary: Strong direct evidence - PMID:16648175 shows AMPK activation in ischemic heart. Direct biochemical demonstration of kinase activity.
Supporting Evidence:
PMID:16648175
Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart
|
|
GO:0005515
protein binding
|
IPI
PMID:16648175 Activation of AMPK alpha- and gamma-isoform complexes in the... |
REMOVE |
Summary: Too general - while AMPK binds proteins, more specific terms are preferable. Remove as uninformative.
Supporting Evidence:
PMID:16648175
Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart.
|
|
GO:0005524
ATP binding
|
IDA
PMID:16648175 Activation of AMPK alpha- and gamma-isoform complexes in the... |
ACCEPT |
Summary: Strong evidence - PMID:16648175 demonstrates ATP requirement for AMPK activity. Core function already accepted from IEA.
Supporting Evidence:
PMID:16648175
Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart
|
|
GO:0004672
protein kinase activity
|
IDA
PMID:12065578 Coordinate regulation of malonyl-CoA decarboxylase, sn-glyce... |
REMOVE |
Summary: Too general - more specific serine/threonine and AMP-activated kinase terms already accepted. Remove redundant broad term.
Supporting Evidence:
PMID:12065578
2002 Jun 13. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
|
|
GO:0019216
regulation of lipid metabolic process
|
IDA
PMID:12065578 Coordinate regulation of malonyl-CoA decarboxylase, sn-glyce... |
ACCEPT |
Summary: Strong evidence - PMID:12065578 shows AMPK regulation of ACC and other lipid metabolic enzymes. Well-established function.
Supporting Evidence:
PMID:12065578
Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise
|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: AMPK localizes to both cytoplasm and nucleus depending on cellular conditions. Nuclear localization is particularly important for its histone H2B phosphorylation function and direct transcriptional regulation under stress conditions. The α2 subunit can translocate to nucleus where it phosphorylates chromatin targets and interacts with transcriptional machinery.
Reason: Nuclear localization is essential for AMPK's stress-responsive chromatin modifying activities and direct transcriptional regulation, representing a key aspect of its energy-sensing function beyond cytoplasmic metabolism.
|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: The cytoplasm is the primary location for AMPK's core metabolic regulatory functions. Here AMPK phosphorylates key metabolic enzymes including ACC (fatty acid synthesis), PFK-2 (glycolysis), HMGCR (cholesterol synthesis), and TSC2/Raptor (mTORC1 signaling). The majority of AMPK's energy-sensing and metabolic control activities occur in this compartment.
Reason: Cytoplasmic localization is fundamental to AMPK's primary role as a metabolic energy sensor. Most of its well-characterized substrate phosphorylation events occur in the cytoplasm where metabolic enzymes and signaling complexes are located.
|
|
GO:1904262
negative regulation of TORC1 signaling
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: AMPK directly inhibits mTORC1 by phosphorylating TSC2 and Raptor, a well-established energy-conservation mechanism. This TORC1-specific term is more precise than the generic negative regulation of TOR signaling annotation and reflects a core downstream signaling role.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
|
|
GO:1990044
protein localization to lipid droplet
|
IBA
GO_REF:0000033 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0031588
nucleotide-activated protein kinase complex
|
IBA
GO_REF:0000033 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated annotation consistent with experimental evidence. Nuclear localization supports stress-responsive functions including histone phosphorylation and transcriptional regulation.
Reason: Supports the manually curated IBA annotation with additional automated evidence for nuclear localization.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated annotation consistent with experimental evidence. Cytoplasmic localization is where AMPK performs most of its metabolic regulatory functions through substrate phosphorylation.
Reason: Supports the manually curated IBA annotation with additional automated evidence for cytoplasmic localization.
|
|
GO:0030424
axon
|
IEA
GO_REF:0000117 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0030425
dendrite
|
IEA
GO_REF:0000117 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0031588
nucleotide-activated protein kinase complex
|
IEA
GO_REF:0000117 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0043025
neuronal cell body
|
IEA
GO_REF:0000117 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005634
nucleus
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: Ortholog-based annotation from mouse-rat comparisons. Nuclear localization is conserved across mammalian AMPK α2 subunits for stress-responsive chromatin functions.
Reason: Strong orthology evidence supports nuclear localization, consistent with other annotation types.
|
|
GO:0031588
nucleotide-activated protein kinase complex
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0031669
cellular response to nutrient levels
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0004679
AMP-activated protein kinase activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0005829
cytosol
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005654
nucleoplasm
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005794
Golgi apparatus
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0016607
nuclear speck
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0036064
ciliary basal body
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:1904262
negative regulation of TORC1 signaling
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity support for AMPK-mediated inhibition of mTORC1 via TSC2/Raptor phosphorylation. Consistent with the curated IBA annotation for this TORC1-specific term.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
|
|
GO:1904262
negative regulation of TORC1 signaling
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: Ortholog-based support for AMPK-mediated inhibition of mTORC1. Consistent with the curated IBA/ISS annotations for this TORC1-specific term.
|
|
GO:0002181
cytoplasmic translation
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0009267
cellular response to starvation
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0034198
cellular response to amino acid starvation
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0038202
TORC1 signaling
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0042149
cellular response to glucose starvation
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0045947
negative regulation of translational initiation
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0045948
positive regulation of translational initiation
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0061462
protein localization to lysosome
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0085020
protein K6-linked ubiquitination
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:1904263
positive regulation of TORC1 signaling
|
ISO
GO_REF:0000121 |
REMOVE |
Summary: Direction contradicts AMPK's canonical and well-established role - AMPKα2 is a negative regulator of mTORC1 (via TSC2/Raptor phosphorylation), not a positive regulator. This ortholog-transferred annotation attributes the opposite regulatory direction and is factually incorrect, not merely imprecise, so it should be removed.
Supporting Evidence:
file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
|
|
GO:0004674
protein serine/threonine kinase activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0140823
histone H2BS36 kinase activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:1905691
lipid droplet disassembly
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:1990044
protein localization to lipid droplet
|
ISS
GO_REF:0000024 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:1990044
protein localization to lipid droplet
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0006646
phosphatidylethanolamine biosynthetic process
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0006656
phosphatidylcholine biosynthetic process
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0090200
positive regulation of release of cytochrome c from mitochondria
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0097284
hepatocyte apoptotic process
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:1903944
negative regulation of hepatocyte apoptotic process
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005737
cytoplasm
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: Ortholog-based annotation from mouse-rat comparisons. Cytoplasmic localization is conserved across mammalian AMPK α2 subunits for metabolic regulatory functions.
Reason: Strong orthology evidence supports cytoplasmic localization, consistent with other annotation types and functional requirements.
|
|
GO:0062028
regulation of stress granule assembly
|
ISO
GO_REF:0000121 |
MARK AS OVER ANNOTATED |
Summary: Likely over-annotation; term is too broad for PRKAA2.
|
|
GO:0010494
cytoplasmic stress granule
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0010629
negative regulation of gene expression
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0030424
axon
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0030424
axon
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:25788287
2015 Mar 18. Polarized activities of AMPK and BRSK in primary hippocampal neurons.
|
|
GO:0030425
dendrite
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0030425
dendrite
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:25788287
2015 Mar 18. Polarized activities of AMPK and BRSK in primary hippocampal neurons.
|
|
GO:0034599
cellular response to oxidative stress
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0043025
neuronal cell body
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0043025
neuronal cell body
|
IMP
PMID:25788287 Polarized activities of AMPK and BRSK in primary hippocampal... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:25788287
2015 Mar 18. Polarized activities of AMPK and BRSK in primary hippocampal neurons.
|
|
GO:0070507
regulation of microtubule cytoskeleton organization
|
ISO
GO_REF:0000121 |
MARK AS OVER ANNOTATED |
Summary: Likely over-annotation; term is too broad for PRKAA2.
|
|
GO:0071277
cellular response to calcium ion
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0071333
cellular response to glucose stimulus
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:1903829
positive regulation of protein localization
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0010468
regulation of gene expression
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0014850
response to muscle activity
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0071466
cellular response to xenobiotic stimulus
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0016241
regulation of macroautophagy
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0071380
cellular response to prostaglandin E stimulus
|
ISO
GO_REF:0000121 |
MARK AS OVER ANNOTATED |
Summary: Likely over-annotation; term is too broad for PRKAA2.
|
|
GO:0004712
protein serine/threonine/tyrosine kinase activity
|
ISO
GO_REF:0000121 |
REMOVE |
Summary: Annotation is overly general or unsupported in this context and should be removed.
|
|
GO:0003682
chromatin binding
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0008610
lipid biosynthetic process
|
ISO
GO_REF:0000121 |
REMOVE |
Summary: Annotation is overly general or unsupported in this context and should be removed.
|
|
GO:0010508
positive regulation of autophagy
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0032007
negative regulation of TOR signaling
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0042752
regulation of circadian rhythm
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0043066
negative regulation of apoptotic process
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: Evidence supports the term but it is not core to PRKAA2 function.
|
|
GO:0042593
glucose homeostasis
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation consistent with curated evidence for this term.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:18256313 Control of glycogen synthase through ADIPOR1-AMPK pathway in... |
ACCEPT |
Summary: Direct experimental evidence from PMID:18256313 showing AMPK localization in renal epithelial cells. Cytoplasmic localization is essential for AMPK's role in controlling glycogen synthase and other metabolic targets in response to energy stress.
Reason: Strong experimental evidence for cytoplasmic localization where AMPK performs its primary metabolic regulatory functions.
Supporting Evidence:
PMID:18256313
Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats.
|
|
GO:0016324
apical plasma membrane
|
IDA
PMID:18256313 Control of glycogen synthase through ADIPOR1-AMPK pathway in... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:18256313
Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats.
|
|
GO:0032991
protein-containing complex
|
IDA
PMID:14511394 Complexes between the LKB1 tumor suppressor, STRAD alpha/bet... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:14511394
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
|
|
GO:0031588
nucleotide-activated protein kinase complex
|
IDA
PMID:16648175 Activation of AMPK alpha- and gamma-isoform complexes in the... |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
Supporting Evidence:
PMID:16648175
Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-RNO-164087 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
|
GO:0005654
nucleoplasm
|
TAS
Reactome:R-RNO-164106 |
UNDECIDED |
Summary: Not reviewed in this pass; requires literature review.
|
Q: How do the α1 and α2 subunits of AMPK differ in their tissue distribution, regulation, and substrate specificity?
Q: What determines the subcellular localization of PRKAA2-containing AMPK complexes and how does this affect their function?
Q: How does PRKAA2 contribute to metabolic sensing and energy homeostasis in different physiological conditions?
Q: What role does PRKAA2 play in cellular stress responses beyond its canonical metabolic functions?
Q: Does AMPKα2's binding and stabilization of SCOT (succinyl-CoA:3-ketoacid CoA transferase) in skeletal muscle ketone utilization represent a broader non-catalytic scaffolding function, and can this stabilization mechanism be confirmed in rat tissues?
Experiment: Proteomics analysis to identify PRKAA2-specific substrates and interacting partners compared to PRKAA1
Experiment: Live-cell imaging using FRET-based biosensors to monitor PRKAA2-containing AMPK activity in real-time
Experiment: Metabolomics analysis of tissues from PRKAA2 knockout mice to understand metabolic pathway alterations
Experiment: Single-cell analysis of AMPK activity and metabolic state in different cell types using genetically encoded indicators
Experiment: Co-immunoprecipitation and cycloheximide-chase protein stability assays in rat skeletal muscle to test whether AMPKα2 binds and stabilizes SCOT (succinyl-CoA:3-ketoacid CoA transferase) and limits its ubiquitin/proteasome-mediated degradation, probing a non-catalytic scaffolding role in ketone utilization
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target gene/protein is Prkaa2 from Rattus norvegicus (rat), corresponding to the catalytic α2 isoform of AMP-activated protein kinase (AMPKα2), orthologous to human PRKAA2. Multiple sources explicitly map Prkaa2/PRKAA2 → AMPKα2 and describe AMPK as a heterotrimeric Ser/Thr kinase with α as the catalytic subunit. (kim2025thelinkbetween pages 5-7, rakoubian2025isoformspecificrolesof pages 8-9, hauger2024shearstressinducedampactivated pages 2-4)
Note: Within the retrieved corpus, no full-text explicitly states the UniProt accession Q09137. However, the gene symbol, isoform, enzymatic class (Ser/Thr kinase), and activation-site/regulatory architecture in the literature match the UniProt-provided identity for rat AMPKα2. (kim2025thelinkbetween pages 5-7, ashraf2024finetuningampkin pages 2-2)
AMPK is a heterotrimeric serine/threonine kinase consisting of a catalytic α subunit plus regulatory β and γ subunits. AMPKα exists as two isoforms (α1 and α2), encoded by Prkaa1/Prkaa2 in rodents (PRKAA1/PRKAA2 in humans). (kim2025thelinkbetween pages 5-7, hauger2024shearstressinducedampactivated pages 2-4)
The α subunit provides the catalytic kinase activity and is activated primarily by phosphorylation at a conserved threonine within the activation loop (Thr172 for α2), which is a core mechanistic definition of “AMPK activation.” (rakoubian2025isoformspecificrolesof pages 1-2, rakoubian2025isoformspecificrolesof pages 2-3)
Canonical activation: upstream kinases phosphorylate AMPKα2 at Thr172, with LKB1 frequently highlighted as a primary kinase (particularly in cardiac contexts), and CaMKKβ/CAMKK2 as an alternate calcium-responsive route. (rakoubian2025isoformspecificrolesof pages 1-2, rakoubian2025isoformspecificrolesof pages 2-3)
Allosteric nucleotide sensing: AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation. (mohanty2025rethinkingampka pages 1-2)
Spatial regulation: recent work emphasizes compartmentalized AMPK pools (e.g., lysosomal AMPK) and demonstrates glucose starvation signaling in which AXIN–LKB1 translocates to lysosomes, promoting AMPK-dependent control of mTORC1 signaling. (li2023hierarchicalinhibitionof pages 3-4)
A schematic depiction of AMPK structure and activation (including Thr172 phosphorylation by LKB1/CAMKK2) is shown in figure crops retrieved from a 2024 review. (ashraf2024finetuningampkin media b6222dde, ashraf2024finetuningampkin media d3d7e38d)
Isoform differences matter for functional annotation. A 2024 review summarizes that AMPKα2 contains a nuclear localization signal and can shuttle to the nucleus, whereas AMPKα1 has an export sequence and is primarily cytosolic. (ashraf2024finetuningampkin pages 2-2)
Consistent with this, a cardiac-focused review describes AMPKα2 as present in cytosol and nucleus in cardiomyocytes and emphasizes isoform-specific roles. (rakoubian2025isoformspecificrolesof pages 8-9)
Prkaa2 encodes a protein kinase (EC 2.7.11.1; Ser/Thr kinase). The biochemical reaction is:
ATP + protein(Ser/Thr) → ADP + protein(Ser/Thr)-phosphate
This is operationalized in the literature by phosphorylation of well-established downstream substrates used as readouts of AMPK activation.
Across the evidence set, commonly referenced AMPK substrates include:
- Acetyl-CoA carboxylase (ACC/ACAC) phosphorylation (widely used as a downstream readout of AMPK activity) (li2023hierarchicalinhibitionof pages 3-4)
- HMG-CoA reductase (HMGCR) as a classical metabolic substrate (mohanty2025rethinkingampka pages 1-2)
- Autophagy pathway targets including ULK1 and upstream inhibition of mTORC1 (rakoubian2025isoformspecificrolesof pages 2-3, jang2023thrap3promotesnonalcoholic pages 1-2)
While not all residue numbers are available in the extracted snippets, the substrate set is consistent with AMPK’s established role: inhibiting anabolic lipid/cholesterol synthesis and promoting catabolic adaptation and autophagy/mitophagy under energy stress. (rakoubian2025isoformspecificrolesof pages 2-3, mohanty2025rethinkingampka pages 1-2)
A 2023 study dissected glucose starvation signaling and concluded that AXIN lysosomal translocation plays a primary role in glucose starvation-triggered inhibition of mTORC1 (via inhibition of RAGs), while AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor, especially under severe stress conditions. Importantly, the paper distinguishes AXIN translocation from AMPK activity (AXIN translocation did not require AMPK), but AMPK activity contributed to mTORC1 inhibition kinetics and residual suppression. (li2023hierarchicalinhibitionof pages 3-4)
This provides a mechanistic pathway-level framework relevant to AMPKα2 function in nutrient sensing (though not strictly α2-exclusive in this experiment set). (li2023hierarchicalinhibitionof pages 3-4)
In a 2023 NAFLD model study, hepatic Thrap3 was increased in NAFLD conditions, and liver-specific Thrap3 knockout improved lipid accumulation and metabolic properties. Mechanistically, Thrap3 deficiency enhanced autophagy and mitochondrial function and increased cytosolic translocation of AMPK from the nucleus, enhancing AMPK activation via physical interaction (with translocation regulated by Thrap3’s C-terminal domain). (jang2023thrap3promotesnonalcoholic pages 1-2)
This supports a functional annotation in which AMPK localization and activation state are dynamically regulated in metabolic disease contexts, and AMPK-mediated autophagy is protective in NAFLD-like phenotypes. (jang2023thrap3promotesnonalcoholic pages 1-2)
A 2024 primary study provides unusually direct α2-isoform-specific physiology. In prolonged fasting (48 h), skeletal muscle-specific AMPKα2 loss produced larger effects on ketone handling than α1 loss:
- AMPKα2ΔMusc mice showed ~2-fold higher blood β-hydroxybutyrate (BHB). (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 2-3)
- AMPKα2ΔMyo mice showed ~1.5–1.6-fold higher blood BHB after 48 h fasting. (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 3-4)
- BHB tolerance assays indicated slower ketone consumption in AMPKα2 muscle knockouts compared with controls. (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 2-3)
Mechanistically, AMPKα2 binds and stabilizes SCOT (succinyl-CoA:3-ketoacid CoA transferase; a rate-limiting ketolysis enzyme) by suppressing its ubiquitination and proteasomal degradation; inhibiting AMPKα2 increased SCOT ubiquitination, and a kinase-dead AMPKα2 reduced SCOT binding and increased SCOT ubiquitination. (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 5-6)
These results place AMPKα2 as an important regulator of skeletal muscle ketone utilization, expanding beyond the classical “AMPK phosphorylates metabolic enzymes” framing into direct regulation of ketolysis enzyme stability. (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 5-6)
Evidence across sources supports multi-compartment operation:
- Nucleus/cytosol shuttling: AMPKα2 has a nuclear localization signal and can shuttle to the nucleus (isoform-biased relative to α1). (ashraf2024finetuningampkin pages 2-2)
- Nuclear–cytosolic redistribution in disease: NAFLD-related Thrap3 regulation alters AMPK distribution, with increased cytosolic translocation associated with increased AMPK activation. (jang2023thrap3promotesnonalcoholic pages 1-2)
- Lysosome-associated nutrient sensing: glucose starvation signaling positions AMPK activity within a lysosome-centered signaling hub through AXIN–LKB1 lysosomal translocation and downstream mTORC1 control. (li2023hierarchicalinhibitionof pages 3-4)
Together, these support annotating AMPKα2 as functioning in both cytosolic metabolic regulation and nuclear programs (via shuttling), with important regulation at organelle-associated signaling sites (e.g., lysosome). (ashraf2024finetuningampkin pages 2-2, li2023hierarchicalinhibitionof pages 3-4)
Key 2023–2024 advances captured in the retrieved set include:
1. Lysosomal pathway hierarchy in glucose starvation: separation of AXIN lysosomal translocation effects from AMPK-dependent mTORC1 inhibition (a more refined view of nutrient stress signaling). (Published Mar 2023) (li2023hierarchicalinhibitionof pages 3-4)
2. NAFLD mechanism via AMPK compartmental regulation: Thrap3 acting as a negative regulator of AMPK-mediated autophagy in fatty liver disease models, implicating AMPK localization as a regulated step. (Published Aug 2023) (jang2023thrap3promotesnonalcoholic pages 1-2)
3. New α2-specific metabolic phenotype: AMPKα2 regulating systemic fasting ketone homeostasis through skeletal muscle ketolysis (SCOT stabilization), with quantitative fold-change phenotypes. (Published Jan 2024) (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 3-4)
4. Updated isoform localization summary and activation schematic: a 2024 review distills isoform-biased nuclear localization and upstream kinase mechanisms (LKB1/CAMKK2), and provides a conceptual framework via curated mouse mutant models. (Published Aug 2024) (ashraf2024finetuningampkin pages 2-2, ashraf2024finetuningampkin media b6222dde)
AMPK is widely targeted pharmacologically (directly or indirectly) in metabolic and cardiovascular contexts.
- Experimental activation (AICAR): AICAR is used as an AMP mimetic to activate AMPK pools and drive mTORC1 inhibition under severe stress; mechanistic dependencies (e.g., on AXIN in some contexts) were tested in 2023 work. (li2023hierarchicalinhibitionof pages 3-4)
- Clinical/real-world drug linkage (metformin): While metformin has multiple mechanisms, a 2024 cardiotoxicity study identifies AMPK pathway restoration by metformin as protective in a drug-induced cardiotoxicity model, consistent with clinical interest in AMPK modulation for cardiometabolic protection. (rakoubian2025isoformspecificrolesof pages 2-3)
A 2024 endothelial-focused review frames AMPK as mechanosensitive (responsive to shear stress) and positions pharmacologic targeting of AMPK as a promising strategy in cardiovascular disease contexts such as atherosclerosis/ischemic injury, reflecting ongoing translational interest. (Published May 2024) (hauger2024shearstressinducedampactivated pages 2-4)
A 2024 review on AMPK point-mutant mouse models emphasizes that AMPK controls diverse outcomes by phosphorylating many substrates, and that in vivo dissection of these substrate relationships remains an active area—supporting the interpretation that isoform, compartment, and substrate context determine physiological output. (ashraf2024finetuningampkin pages 2-2)
A 2024 vascular review similarly emphasizes AMPK as a central node linking mechanical cues to metabolic adaptations and disease modulation, aligning with a broad expert consensus that AMPK signaling is not purely “metabolic,” but integrates stress signals (mechanical, nutrient, calcium) into multi-system physiology. (hauger2024shearstressinducedampactivated pages 2-4)
These quantitative findings are among the most direct isoform-specific physiological readouts in the retrieved 2023–2024 primary literature set and should be prioritized for functional annotation. (zhang2024ampkα2regulatesfastinginduced pages 1-2)
Prkaa2 encodes AMPKα2, a catalytic Ser/Thr protein kinase subunit within AMPK that is activated by Thr172 phosphorylation (primarily via LKB1 and alternatively CaMKKβ/CAMKK2) and by adenine nucleotide sensing. AMPKα2 functions across cytosol–nucleus (isoform-biased nuclear shuttling) and participates in organelle-centered nutrient sensing (lysosome-associated control of mTORC1). Functionally, AMPKα2 integrates energy stress to inhibit anabolic metabolism and promote catabolism and autophagy; recent primary evidence further supports a specific role in skeletal muscle ketone utilization through stabilization of the ketolysis enzyme SCOT. (rakoubian2025isoformspecificrolesof pages 1-2, ashraf2024finetuningampkin pages 2-2, zhang2024ampkα2regulatesfastinginduced pages 1-2, li2023hierarchicalinhibitionof pages 3-4)
| Aspect | Key points | Evidence (citation IDs) | Year/Source (short) |
|---|---|---|---|
| Molecular function | Prkaa2 encodes AMPKα2, the catalytic α2 subunit of the heterotrimeric AMPK Ser/Thr kinase. AMPKα2 phosphorylates metabolic targets including ACC/ACAC (canonical readout; ACC Ser79 commonly used), HMGCR, and autophagy regulators such as ULK1; recent reviews also note mitochondrial fission target MFF Ser172. Overall role is to suppress anabolic metabolism and promote catabolic, ATP-restoring pathways. | (feng2025theroleof pages 2-3, rakoubian2025isoformspecificrolesof pages 2-3, mohanty2025rethinkingampka pages 1-2) | 2025 Feng review; 2025 Rakoubian review; 2025 Mohanty review |
| Activation and regulation | Core activation is phosphorylation of AMPKα2 at Thr172 by upstream kinases, especially LKB1; CaMKKβ/CAMKK2 provides a Ca2+-responsive route. AMP/ADP binding to γ promotes allostery, favors Thr172 phosphorylation, and protects from dephosphorylation. AXIN-LKB1 lysosomal signaling helps couple glucose starvation to AMPK-dependent mTORC1 inhibition; ADaM-site ligands stabilize AMPK and protect Thr172. | (rakoubian2025isoformspecificrolesof pages 1-2, ashraf2024finetuningampkin pages 2-2, rakoubian2025isoformspecificrolesof pages 2-3, li2023hierarchicalinhibitionof pages 3-4, ashraf2024finetuningampkin media b6222dde) | 2025 Rakoubian review; 2024 Ashraf review; 2023 Li primary; 2024 figure summary |
| Localization | AMPKα2 shows isoform-biased nuclear localization/shuttling, whereas α1 is mainly cytosolic. Reviews summarize that α2 contains a nuclear localization signal and can shuttle to the nucleus; α1 carries a nuclear export sequence. In heart, α2 is described as present in both cytosol and nucleus and enriched in cardiomyocytes. | (feng2025theroleof pages 2-3, rakoubian2025isoformspecificrolesof pages 8-9, ashraf2024finetuningampkin pages 2-2, ashraf2024finetuningampkin media d3d7e38d) | 2025 Feng review; 2025 Rakoubian review; 2024 Ashraf review/figure context |
| Isoform-specific role: ketone metabolism | A 2024 primary study identified a specific AMPKα2 role in skeletal-muscle ketone utilization: fasting AMPKα2ΔMusc mice showed ~2-fold higher blood BHB, and AMPKα2ΔMyo mice ~1.5–1.6-fold higher blood BHB after 48 h fasting versus WT; AMPKα2 loss slowed BHB clearance. Mechanistically, AMPKα2 binds and stabilizes SCOT, limiting SCOT ubiquitination/degradation. | (zhang2024ampkα2regulatesfastinginduced pages 1-2, zhang2024ampkα2regulatesfastinginduced pages 3-4, zhang2024ampkα2regulatesfastinginduced pages 2-3, zhang2024ampkα2regulatesfastinginduced pages 5-6) | 2024 Zhang et al., Scientific Reports |
| Isoform specificity and tissue distribution | α2 is preferentially enriched in skeletal muscle, cardiac muscle, and liver and can be more AMP responsive than α1. In heart, α2 is the predominant catalytic isoform and α1 does not fully compensate for α2 loss in stress adaptation. | (kim2025thelinkbetween pages 5-7, rakoubian2025isoformspecificrolesof pages 8-9, ashraf2024finetuningampkin pages 2-2) | 2025 Kim review; 2025 Rakoubian review; 2024 Ashraf review |
| Pathways/processes | Major downstream processes include inhibition of mTORC1, activation of autophagy/mitophagy, stimulation of mitochondrial adaptation/biogenesis, and broad metabolic reprogramming during nutrient stress and exercise. | (rakoubian2025isoformspecificrolesof pages 2-3, malik2025theampkpathway pages 3-4, jang2023thrap3promotesnonalcoholic pages 1-2) | 2025 Rakoubian review; 2025 Malik review; 2023 Jang primary |
| Example context: NAFLD | In NAFLD models, Thrap3 suppresses AMPK-mediated autophagy; liver Thrap3 knockout enhanced cytosolic translocation of AMPK from the nucleus, increased AMPK activation, improved mitochondrial function, and reduced lipid accumulation, supporting therapeutic interest in restoring AMPK signaling. | (jang2023thrap3promotesnonalcoholic pages 1-2) | 2023 Jang et al., Exp Mol Med |
| Example context: cardiotoxicity | In a 2024 cardiotoxicity study, impaired PRKAA/AMPK signaling contributed to defective autophagosome-lysosome fusion during crizotinib injury; metformin restored AMPK-related signaling and rescued cardiomyocyte/cardiac injury phenotypes. ACC Ser79 phosphorylation was used as a PRKAA target readout. | (rakoubian2025isoformspecificrolesof pages 2-3) | 2024 Xu et al., Autophagy |
| Example context: endothelial shear stress / vascular biology | Recent vascular review literature describes AMPK, including PRKAA2/AMPKα2, as a mechanosensitive endothelial regulator linking laminar shear stress to metabolic adaptation and vascular protection; it is discussed as a therapeutic target in cardiovascular disease. | (hauger2024shearstressinducedampactivated pages 2-4) | 2024 Hauger & Hordijk review |
Table: This table summarizes the core functional annotation of rat Prkaa2/AMPKα2, including molecular activity, activation mechanisms, localization, isoform-specific phenotypes, and representative disease contexts. It is useful as a compact evidence map tying recent literature to functional interpretation.
References
(kim2025thelinkbetween pages 5-7): Sohyun Kim, Jihyun Baek, and Man S. Kim. The link between dietary timing and exercise performance through adipocyte ampkα2 signaling. International Journal of Molecular Sciences, 26:6061, Jun 2025. URL: https://doi.org/10.3390/ijms26136061, doi:10.3390/ijms26136061. This article has 4 citations.
(rakoubian2025isoformspecificrolesof pages 8-9): Ani Rakoubian, Julia Khinchin, Johnathan Yarbro, Satoru Kobayashi, and Qiangrong Liang. Isoform-specific roles of amp-activated protein kinase in cardiac physiology and pathophysiology. Frontiers in Cardiovascular Medicine, Aug 2025. URL: https://doi.org/10.3389/fcvm.2025.1638515, doi:10.3389/fcvm.2025.1638515. This article has 13 citations and is from a peer-reviewed journal.
(hauger2024shearstressinducedampactivated pages 2-4): Philipp C. Hauger and Peter L. Hordijk. Shear stress-induced amp-activated protein kinase modulation in endothelial cells: its role in metabolic adaptions and cardiovascular disease. International Journal of Molecular Sciences, 25:6047, May 2024. URL: https://doi.org/10.3390/ijms25116047, doi:10.3390/ijms25116047. This article has 18 citations.
(ashraf2024finetuningampkin pages 2-2): Naghmana Ashraf and Jeanine L. Van Nostrand. Fine-tuning ampk in physiology and disease using point-mutant mouse models. Disease Models & Mechanisms, Aug 2024. URL: https://doi.org/10.1242/dmm.050798, doi:10.1242/dmm.050798. This article has 11 citations and is from a domain leading peer-reviewed journal.
(rakoubian2025isoformspecificrolesof pages 1-2): Ani Rakoubian, Julia Khinchin, Johnathan Yarbro, Satoru Kobayashi, and Qiangrong Liang. Isoform-specific roles of amp-activated protein kinase in cardiac physiology and pathophysiology. Frontiers in Cardiovascular Medicine, Aug 2025. URL: https://doi.org/10.3389/fcvm.2025.1638515, doi:10.3389/fcvm.2025.1638515. This article has 13 citations and is from a peer-reviewed journal.
(rakoubian2025isoformspecificrolesof pages 2-3): Ani Rakoubian, Julia Khinchin, Johnathan Yarbro, Satoru Kobayashi, and Qiangrong Liang. Isoform-specific roles of amp-activated protein kinase in cardiac physiology and pathophysiology. Frontiers in Cardiovascular Medicine, Aug 2025. URL: https://doi.org/10.3389/fcvm.2025.1638515, doi:10.3389/fcvm.2025.1638515. This article has 13 citations and is from a peer-reviewed journal.
(mohanty2025rethinkingampka pages 1-2): Shraddha S. Mohanty, Shweta Warrier, and Annapoorni Rangarajan. Rethinking ampk: a reversible switch fortifying cancer cell stress-resilience. The Yale Journal of Biology and Medicine, 98:33-52, Mar 2025. URL: https://doi.org/10.59249/jkbb6336, doi:10.59249/jkbb6336. This article has 10 citations.
(li2023hierarchicalinhibitionof pages 3-4): Mengqi Li, Xiaoyan Wei, Jinye Xiong, Jin-Wei Feng, Chen-Song Zhang, and Sheng-Cai Lin. Hierarchical inhibition of mtorc1 by glucose starvation-triggered axin lysosomal translocation and by ampk. Life Metabolism, Mar 2023. URL: https://doi.org/10.1093/lifemeta/load005, doi:10.1093/lifemeta/load005. This article has 25 citations.
(ashraf2024finetuningampkin media b6222dde): Naghmana Ashraf and Jeanine L. Van Nostrand. Fine-tuning ampk in physiology and disease using point-mutant mouse models. Disease Models & Mechanisms, Aug 2024. URL: https://doi.org/10.1242/dmm.050798, doi:10.1242/dmm.050798. This article has 11 citations and is from a domain leading peer-reviewed journal.
(ashraf2024finetuningampkin media d3d7e38d): Naghmana Ashraf and Jeanine L. Van Nostrand. Fine-tuning ampk in physiology and disease using point-mutant mouse models. Disease Models & Mechanisms, Aug 2024. URL: https://doi.org/10.1242/dmm.050798, doi:10.1242/dmm.050798. This article has 11 citations and is from a domain leading peer-reviewed journal.
(jang2023thrap3promotesnonalcoholic pages 1-2): Hyun-Jun Jang, Yo Han Lee, Tam Dao, Yunju Jo, Keon Woo Khim, Hye-jin Eom, Ju Eun Lee, Yi Jin Song, Sun Sil Choi, Kieun Park, Haneul Ji, Young Chan Chae, Kyungjae Myung, Hongtae Kim, Dongryeol Ryu, Neung Hwa Park, Sung Ho Park, and Jang Hyun Choi. Thrap3 promotes nonalcoholic fatty liver disease by suppressing ampk-mediated autophagy. Experimental & Molecular Medicine, 55:1720-1733, Aug 2023. URL: https://doi.org/10.1038/s12276-023-01047-4, doi:10.1038/s12276-023-01047-4. This article has 21 citations and is from a peer-reviewed journal.
(zhang2024ampkα2regulatesfastinginduced pages 1-2): Lingxue Zhang, Yanqiao Lu, Junqing An, Yin Wu, Zhixue Liu, and Ming-Hui Zou. Ampkα2 regulates fasting-induced hyperketonemia by suppressing scot ubiquitination and degradation. Scientific Reports, Jan 2024. URL: https://doi.org/10.1038/s41598-023-49991-5, doi:10.1038/s41598-023-49991-5. This article has 6 citations and is from a peer-reviewed journal.
(zhang2024ampkα2regulatesfastinginduced pages 2-3): Lingxue Zhang, Yanqiao Lu, Junqing An, Yin Wu, Zhixue Liu, and Ming-Hui Zou. Ampkα2 regulates fasting-induced hyperketonemia by suppressing scot ubiquitination and degradation. Scientific Reports, Jan 2024. URL: https://doi.org/10.1038/s41598-023-49991-5, doi:10.1038/s41598-023-49991-5. This article has 6 citations and is from a peer-reviewed journal.
(zhang2024ampkα2regulatesfastinginduced pages 3-4): Lingxue Zhang, Yanqiao Lu, Junqing An, Yin Wu, Zhixue Liu, and Ming-Hui Zou. Ampkα2 regulates fasting-induced hyperketonemia by suppressing scot ubiquitination and degradation. Scientific Reports, Jan 2024. URL: https://doi.org/10.1038/s41598-023-49991-5, doi:10.1038/s41598-023-49991-5. This article has 6 citations and is from a peer-reviewed journal.
(zhang2024ampkα2regulatesfastinginduced pages 5-6): Lingxue Zhang, Yanqiao Lu, Junqing An, Yin Wu, Zhixue Liu, and Ming-Hui Zou. Ampkα2 regulates fasting-induced hyperketonemia by suppressing scot ubiquitination and degradation. Scientific Reports, Jan 2024. URL: https://doi.org/10.1038/s41598-023-49991-5, doi:10.1038/s41598-023-49991-5. This article has 6 citations and is from a peer-reviewed journal.
(feng2025theroleof pages 2-3): Yue Feng, Zixiong Zhu, Yubin He, and Xuewen Li. The role of ampkα in the mechanism of development and treatment of heart failure. Reviews in Cardiovascular Medicine, Aug 2025. URL: https://doi.org/10.31083/rcm36391, doi:10.31083/rcm36391. This article has 5 citations and is from a peer-reviewed journal.
(malik2025theampkpathway pages 3-4): Nazma Malik and R. Shaw. The ampk pathway: molecular rejuvenation of metabolism and mitochondria. Annual review of cell and developmental biology, Aug 2025. URL: https://doi.org/10.1146/annurev-cellbio-120420-094431, doi:10.1146/annurev-cellbio-120420-094431. This article has 29 citations and is from a domain leading peer-reviewed journal.
Generated using OpenAI Deep Research API
Prkaa2 encodes the AMP-activated protein kinase (AMPK) catalytic α2 subunit, a serine/threonine kinase that serves as a central energy sensor and regulator of metabolism (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). The α2 subunit, together with regulatory β and γ subunits, forms the heterotrimeric AMPK complex which is activated under conditions of low cellular energy (high AMP/ADP relative to ATP) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Activation requires phosphorylation of a critical threonine (Thr^172) in the α2 subunit’s activation loop by upstream kinases such as LKB1 or CaMKK2 (pmc.ncbi.nlm.nih.gov). Once active, AMPKα2 phosphorylates numerous downstream targets to restore energy homeostasis – for example, it inactivates acetyl-CoA carboxylase (ACC) and HMG-CoA reductase, thereby down-regulating fatty acid and cholesterol synthesis while up-regulating fatty acid oxidation (rgd.mcw.edu) (rgd.mcw.edu). It also phosphorylates proteins like TSC2 and Raptor to inhibit mTORC1 signaling, conserving energy under stress (rgd.mcw.edu). Notably, AMPKα2 can directly modulate nuclear processes: a landmark study showed it associates with chromatin and phosphorylates histone H2B at Ser36, activating stress-response gene transcription (www.ncbi.nlm.nih.gov). In summary, Prkaa2’s product functions as a catalytic kinase subunit with “AMP-activated protein kinase activity”, binding ATP and magnesium (as a typical protein serine/threonine kinase) (rgd.mcw.edu), and acting as a molecular switch that shifts cells from energy-consuming processes to energy-producing pathways during metabolic stress (pmc.ncbi.nlm.nih.gov) (rgd.mcw.edu).
The AMPKα2 protein is predominantly a cytosolic kinase, but it dynamically localizes to multiple cellular compartments. It resides in the “nucleotide-activated protein kinase complex” (AMPK heterotrimer) within the cytoplasm and can translocate to the nucleus upon activation (rgd.mcw.edu) (pubmed.ncbi.nlm.nih.gov). In fact, complexes containing the α2 isoform show a tendency for nuclear localization and greater AMP-dependence compared to α1-containing complexes (pubmed.ncbi.nlm.nih.gov). Activated AMPKα2 has been observed in the nucleoplasm and even at nuclear speckles, consistent with its role in regulating transcription and chromatin remodeling (rgd.mcw.edu). Prkaa2 is also found at specialized subcellular sites: the protein has been detected in neuronal cell bodies and dendrites (www.ncbi.nlm.nih.gov), and at the apical plasma membrane in polarized cells (www.ncbi.nlm.nih.gov). Recent studies highlight that AMPK complexes can localize to organelle surfaces – for example, AMPK is recruited to lysosomal membranes during glucose starvation, where a scaffold (AXIN-LKB1) facilitates AMPKα2 phosphorylation and activation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Thus, AMPKα2’s localization is both cytoplasmic and nuclear, with additional compartment-specific tethering (lysosome, endoplasmic reticulum, etc.) to fine-tune its signaling in response to cellular stress (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These localization properties enable AMPKα2 to access substrates throughout the cell, from metabolic enzymes in the cytosol to transcriptional regulators in the nucleus.
Prkaa2 (AMPKα2) is a master regulator in numerous biological processes related to energy balance and metabolism. A primary role is maintaining energy homeostasis at both cellular and whole-organism levels (rgd.mcw.edu) (pmc.ncbi.nlm.nih.gov). When activated by rising AMP/ADP, AMPKα2 triggers catabolic pathways that generate ATP and suppresses anabolic pathways that consume ATP (pmc.ncbi.nlm.nih.gov). For example, AMPKα2 positively regulates glucose uptake and glycolysis (enhancing ATP production) (rgd.mcw.edu) (rgd.mcw.edu), and it stimulates fatty acid oxidation while inhibiting fatty acid and lipid biosynthesis (rgd.mcw.edu). It also acutely inhibits cholesterol synthesis via phosphorylation of HMG-CoA reductase (rgd.mcw.edu). These actions translate to higher-order processes like glucose homeostasis and lipid homeostasis in tissues (rgd.mcw.edu) (rgd.mcw.edu). AMPKα2 is a key upstream regulator of autophagy – energy stress causes AMPKα2 to activate autophagy pathways (e.g. via ULK1 phosphorylation), promoting recycling of nutrients (rgd.mcw.edu) (rgd.mcw.edu). Concurrently, it negatively regulates growth and proliferative signals: AMPKα2 inhibits the TORC1 (mTOR) signaling pathway under low energy, restraining protein synthesis and cell growth (rgd.mcw.edu). AMPKα2 activation can also protect against apoptosis during mild stress, evidenced by its role in the negative regulation of apoptotic processes and promotion of cell survival pathways (rgd.mcw.edu). Additionally, Prkaa2 is involved in cellular stress responses to various stimuli – it participates in the response to glucose starvation, nutrient deprivation, oxidative stress, calcium influx, and even xenobiotic exposure (rgd.mcw.edu) (rgd.mcw.edu). Intriguingly, AMPKα2 has been implicated in regulating circadian rhythm and gene expression, linking metabolic state to the circadian clock and transcriptional programs (rgd.mcw.edu) (rgd.mcw.edu). Overall, through the AMPKα2 subunit, Prkaa2 influences a broad network of biological pathways including the AMPK signaling pathway, insulin signaling, mTOR signaling, and pathways governing lipid metabolism and autophagy (rgd.mcw.edu). This breadth of action underscores AMPKα2’s central role in balancing anabolic and catabolic processes across diverse contexts.
Given its central metabolic role, dysregulation of Prkaa2/AMPKα2 is linked to multiple diseases and phenotypic outcomes. In rodent models, loss or inhibition of AMPKα2 leads to metabolic disturbances: AMPKα2-knockout mice exhibit glucose intolerance and insulin resistance, demonstrating the subunit’s importance in whole-body insulin sensitivity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Specifically, AMPKα2–/– mice have elevated blood glucose and impaired muscle glucose uptake and glycogen synthesis under insulin stimulation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This phenotype is accompanied by low plasma insulin and increased catecholamine levels, suggesting that AMPKα2 helps restrain sympathetic output to promote insulin secretion and action (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Consistent with these findings, the human ortholog PRKAA2 has been implicated in type 2 diabetes mellitus susceptibility (www.ncbi.nlm.nih.gov). Polymorphisms in human PRKAA2 associate with risk of type 2 diabetes and with altered blood lipid profiles, linking this gene to metabolic syndrome traits (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
AMPKα2 also has a significant role in cardiovascular health. It is highly expressed in cardiac muscle, where it safeguards energy balance in the heart. Experimental studies indicate cardioprotective effects: activation of AMPKα2 (e.g. by the antidiabetic drug metformin) can protect against heart failure or ischemic injury (rgd.mcw.edu). Conversely, dysfunction of AMPKα2 is associated with cardiac pathology – annotations link Prkaa2 to cardiomegaly, cardiomyopathy, and cardiac fibrosis phenotypes (rgd.mcw.edu). For instance, reduced AMPKα2 activity may contribute to pathological cardiac hypertrophy and fibrotic remodeling, while active AMPKα2 helps maintain cardiac energetics and contractile function (as suggested by improved outcomes with AMPK-activating treatments) (rgd.mcw.edu) (rgd.mcw.edu). In the nervous system, Prkaa2 is expressed in brain neurons and may influence neuronal survival and plasticity during metabolic stress. While severe overactivation of AMPK in neurons can be deleterious (e.g. during ischemia), moderate AMPKα2 activity is thought to support neuronal health during nutrient stress via autophagy induction and metabolic support (rgd.mcw.edu) (www.ncbi.nlm.nih.gov). However, the exact neurological phenotypes require further elucidation.
Importantly, Prkaa2’s involvement in disease is often context-dependent. Its proper function appears to protect against metabolic diseases (diabetes, fatty liver) and cardiovascular diseases, whereas loss of function or improper regulation predisposes to these conditions. Thus, AMPKα2 is viewed as a potential therapeutic target – for example, pharmacological AMPK activators (AICAR, metformin, ALA, etc.) improve metabolic parameters and are being explored for treating insulin resistance and cardiometabolic disorders (rgd.mcw.edu) (rgd.mcw.edu).
The AMPKα2 protein (enzyme commission number EC 2.7.11.31) is approximately 552 amino acids in length and contains several well-defined domains critical for its activity and regulation. At the N-terminus (~residues 1–270) is the serine/threonine kinase domain, which includes the ATP-binding pocket and the activation loop harboring Thr^172 (whose phosphorylation is required for kinase activation) (pmc.ncbi.nlm.nih.gov). This kinase domain conforms to the typical bilobal architecture of protein kinases and binds Mg^2+-ATP, consistent with the enzyme’s ATP binding and metal ion binding activities (rgd.mcw.edu). Following the catalytic domain, the α2 subunit harbors an auto-inhibitory domain (AID) – a segment that can fold back onto the kinase domain to dampen its activity under resting conditions. The AID (identified in AMPKα1 around residues 313–335 and conserved in α2) interacts with the kinase domain and must be disengaged for full activation (pmc.ncbi.nlm.nih.gov). Binding of AMP/ADP to the γ subunit and phosphorylation of Thr^172 both serve to relieve this autoinhibition, prompting a conformational change that activates the kinase (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
The C-terminal region (~residues 331–552) of AMPKα2 is crucial for forming the heterotrimeric complex. It contains a protein-interaction domain that binds the β subunit and, indirectly, the γ subunit, thereby assembling the stable αβγ complex (pmc.ncbi.nlm.nih.gov). Within this region, specific motifs have been identified, such as the α-Subunit Carboxy-terminal Domain (α-CTD) and α-regulatory subunit interacting motif (α-RIM), which contact the γ subunit and mediate the allosteric effects of nucleotide binding (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The β subunit-binding segment of α2 helps tether a β subunit (which itself contains a glycogen-binding domain) – this association can target AMPK to glycogen particles and other cellular structures. Notably, the α2 subunit’s complex with β and γ subunits is sometimes termed a “nucleotide-activated protein kinase complex”, highlighting that AMP/ADP binding to γ subunits regulates the whole complex’s conformation and activity (rgd.mcw.edu). No transmembrane region is present in AMPKα2 (it is a soluble protein), but the complex can associate with membranes via adaptor proteins or by virtue of the β subunit’s myristoylation. In summary, AMPKα2’s domain architecture – kinase domain, autoinhibitory linker, and C-terminal subunit interaction domains – is designed for tight regulation, ensuring the kinase is only active when appropriate (i.e. low energy) and properly integrated into the larger AMPK complex.
Expression of Prkaa2 is widespread in rat tissues but shows higher levels in organs with high energy turnover. RNA expression data indicate biased expression in skeletal muscle and heart, which have among the highest Prkaa2 mRNA levels (for example, skeletal muscle shows the highest RPKM ~915, and heart ~626) (www.ncbi.nlm.nih.gov). This corresponds to protein data showing abundant AMPKα2 in striated muscle (both skeletal and cardiac), reflecting these tissues’ reliance on AMPK for metabolic control during contraction or exercise. Prkaa2 is also significantly expressed in the brain, including regions like the hippocampus and cortex (www.mousephenotype.org) (www.mousephenotype.org), and in metabolically active tissues such as the liver, kidney, and adipose tissue (though in adipose AMPKα1 may be relatively more expressed). In the central nervous system, both neurons and glial cells express AMPKα2; notably, it is present in neuron cell bodies and dendrites (www.ncbi.nlm.nih.gov). Lower but appreciable expression is found in lung, spleen, and testes, indicating a fairly ubiquitous presence consistent with a fundamental cellular role. The AMPKα1 (Prkaa1) isoform is co-expressed in many tissues, often at higher levels in liver and adipose, whereas α2 is predominant in muscle and perhaps neuron-rich areas (pmc.ncbi.nlm.nih.gov).
Regulation of expression: Prkaa2 transcription and protein levels can be modulated by dietary and hormonal signals. For instance, chronic energy surplus or deficit can alter AMPK levels – rodent studies show that exercise training or chronic leptin treatment increases AMPKα2 expression and phosphorylation in muscle (rgd.mcw.edu), potentially as an adaptive response to enhanced fatty acid oxidation demand. Fasting and caloric restriction tend to elevate AMPK activity (through post-translational mechanisms) rather than dramatically changing expression, while high-fat feeding and obesity may reduce AMPKα2 activity (sometimes via reduced expression or increased inhibitory phosphorylation by insulin signaling). Certain AMPK activators (AICAR, metformin) don’t necessarily change AMPKα2 expression but strongly increase its activation state (phospho-Thr^172 levels) (rgd.mcw.edu) (rgd.mcw.edu). Conversely, insulin and high glucose can suppress AMPK activation; insulin signaling leads to Akt-mediated phosphorylation of AMPKα (at Ser485/491 in α1/α2) which can dampen Thr^172 phosphorylation. Stress conditions (hypoxia, ischemia) can elevate AMPKα2 activation; for example, in cardiac ischemia, AMPKα2 is rapidly activated to help ATP generation. On a developmental note, Prkaa2 expression is detectable in embryonic tissues and increases postnatally in heart and muscle as energy demands rise. Additionally, circadian regulators may influence Prkaa2 expression or activity rhythmically, aligning metabolic enzyme oscillations with day-night cycles (rgd.mcw.edu). Overall, Prkaa2 is constitutively expressed in most cell types, with post-translational regulation (AMP/ATP ratio, upstream kinases) being the dominant mode of controlling AMPKα2 activity, though gene expression can be upregulated by chronic metabolic challenges or endurance training.
The AMPKα2 protein is highly conserved across eukaryotic evolution, underscoring its fundamental role in cellular physiology. Prkaa2 belongs to the SNF1/AMPK family of protein kinases, which first appeared in single-celled eukaryotes. The canonical energy-sensing kinase in budding yeast, SNF1, is an ortholog of AMPKα – it likewise forms a heterotrimer (Snf1 catalytic with Snf4 regulatory subunit) and responds to nutrient stress, indicating a common ancestral energy-sensing mechanism (pmc.ncbi.nlm.nih.gov). In mammals, AMPKα2 and its isoform α1 are ~90% identical in the kinase domain and both perform the energy-monitor role, having arisen from gene duplication. Across species, the amino acid sequence of AMPKα2 is strongly conserved: the rat AMPKα2 protein shares ~99% identity with mouse AMPKα2 (reflecting only a few residue differences) and high identity with the human AMPKα2 (PRKAA2) protein (approximately 96–98% identity, with almost all differences in non-critical regions). Key functional motifs – such as the ATP-binding pocket, the activation loop (Thr^172 site), the AID region, and subunit interaction surfaces – are essentially invariant from rodents to humans, highlighting strong purifying selection due to the protein’s vital function (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Even in more distant organisms like Drosophila or C. elegans, the AMPKα catalytic subunit is easily recognizable and can substitute functionally in cross-species experiments, demonstrating conservation of function. The regulatory network is also conserved – the upstream kinase LKB1 and canonical downstream targets (ACC, etc.) exist in all mammals and many metazoans. This evolutionary conservation extends to the GO annotations: for example, “AMP-activated protein kinase activity” and “cellular response to glucose starvation” are attributed to orthologs from yeast (SNF1) through plants (SnRK1 in Arabidopsis) to animals (rgd.mcw.edu). The ancient origin and conservation of Prkaa2’s function emphasize that the ability to sense energy status and adjust metabolism is a fundamental necessity across life.
Numerous studies have elucidated the function of Prkaa2/AMPKα2 through a combination of genetic, biochemical, and physiological approaches:
Gene Knockout Studies: Viollet et al. (2003) generated AMPKα2-knockout mice, revealing that AMPKα2–null animals develop impaired glucose tolerance and insulin resistance, especially under metabolic challenge (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Despite normal muscle AMPKα1, these mice had high fed-state blood glucose and reduced insulin-stimulated glucose disposal, pinpointing AMPKα2’s non-redundant role in maintaining insulin sensitivity in vivo (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This study underscored AMPKα2 as crucial for whole-body metabolic homeostasis.
Enzymatic Activity and Substrates: Foundational biochemical work by Woods, Hardie, Carling, and colleagues characterized AMPK isoforms. Woods et al. (1996) and Salt et al. (1998) showed that AMPK complexes containing the α2 subunit are more sensitive to AMP and may localize to the nucleus preferentially (pubmed.ncbi.nlm.nih.gov). These studies, isolating α1- vs α2-containing complexes, also noted subtle differences in substrate specificity (pubmed.ncbi.nlm.nih.gov). Direct targets of AMPKα2 were identified: for example, Park et al. (2002) demonstrated in rats that exercise activates AMPKα2, leading to phosphorylation of ACC and HMG-CoA reductase in muscle and liver, thereby acutely regulating fatty acid and cholesterol metabolism (rgd.mcw.edu). This provided molecular evidence for AMPKα2’s role in fuel utilization during exercise.
Metabolic Regulation in Muscle: Sakoda et al. (2002) showed that AICAR (an AMP mimetic) increases glucose uptake in skeletal muscle in an AMPK-dependent manner (rgd.mcw.edu). In their experiments, muscle from rats required functional AMPK (particularly α2 in muscle) for AICAR to stimulate glucose transport, whereas adipocytes did not, highlighting tissue-specific roles of AMPKα2 in glucose metabolism. Steinberg et al. (2003) reported that chronic leptin treatment in rodents elevated AMPKα2 activity in muscle, linking hormonal signals to AMPK activation (rgd.mcw.edu).
Nuclear Functions: A seminal discovery by Bungard et al. (2010) revealed a novel nuclear role for AMPKα2: under stress, AMPKα2 translocates to nuclei and phosphorylates histone H2B on Ser36, directly enhancing transcription of stress-response genes (www.ncbi.nlm.nih.gov). This was evidenced by chromatin immunoprecipitation and loss-of-function mutants of H2B S36, demonstrating that this histone mark is required for full transcriptional activation and cell survival during metabolic stress (www.ncbi.nlm.nih.gov). This finding expanded AMPKα2’s functional repertoire beyond metabolism into gene regulation and established a mechanism for how energy stress signals reach the genome.
Cardiac Studies: Research in cardiomyocytes and in vivo hearts (e.g., Tzanavari et al. 2016) showed that pharmacological activation of AMPKα2 (by metformin) protects against sepsis-induced or ischemic cardiac dysfunction (rgd.mcw.edu). Additionally, Sayed-Ahmed et al. (2019) found that preventing AMPK suppression mitigated drug-induced cardiotoxicity (rgd.mcw.edu). These studies highlight AMPKα2 as a key player in cardiac stress adaptation, aligning with GO annotations for positive regulation of autophagy and negative regulation of apoptosis in heart tissue under stress (rgd.mcw.edu) (rgd.mcw.edu).
Structural and Mechanistic Insights: High-resolution crystal structures of AMPK complexes (reviewed by Yan et al. 2018) have visualized the conformational changes of AMPKα2 upon nucleotide binding. These studies confirm that binding of AMP/ADP to the γ subunit and phosphorylation of Thr^172 stabilize the kinase domain in an active conformation and prevent dephosphorylation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Mutagenesis of the autoinhibitory region and α-RIM motifs in AMPKα2 corroborated their roles in sensing AMP and relieving autoinhibition (pmc.ncbi.nlm.nih.gov). Thus, structural biology combined with mutational analyses have provided a molecular basis for GO terms such as “AMP-activated protein kinase activity” and “protein autoinhibition”.
Each of these key experiments has contributed to the understanding captured in Gene Ontology annotations. From molecular function (e.g. “AMP-activated protein kinase activity” (rgd.mcw.edu), “ATP binding” (rgd.mcw.edu)) to biological processes (“fatty acid homeostasis” (www.ncbi.nlm.nih.gov), “response to glucose starvation” (rgd.mcw.edu), “negative regulation of TORC1 signaling” (rgd.mcw.edu), etc.) and cellular components (“AMPK complex” (rgd.mcw.edu), “nucleus” (rgd.mcw.edu), “apical plasma membrane” (www.ncbi.nlm.nih.gov)), the research evidence solidly supports Prkaa2’s multi-faceted role in the cell. This makes Prkaa2 (AMPKα2) a crucial gene for which GO curation captures a wide spectrum of functions – from metabolic enzyme phosphorylation to chromatin modulation – all converging on the theme of energy-sensing and adaptive response.
References: The information above is drawn from a synthesis of literature and databases, including gene/protein databases and key publications (e.g., Hardie DG and colleagues’ work on AMPK, Viollet et al. on knockout phenotypes, and recent molecular studies), as cited in-line. The report provides a foundation for GO annotation by tying specific experimental evidence to GO terms in Gene Ontology for Prkaa2. Each citation (e.g., (www.ncbi.nlm.nih.gov)) corresponds to published data supporting the statement, ensuring that GO curators have source material for each functional aspect described.
PRKAA2 encodes the α2 catalytic subunit of AMPK, which has intrinsic serine/threonine kinase activity. The α2 isoform differs from α1 in tissue distribution and substrate specificity PMID:8955377.
ACC (Acetyl-CoA Carboxylase): Direct phosphorylation inhibits fatty acid synthesis PMID:12065578.
PFK-2 (6-Phosphofructo-2-kinase): Direct phosphorylation at Ser466 activates the enzyme, promoting glycolysis during energy stress PMID:11069105.
ChREBP: Direct phosphorylation at Ser568 inhibits DNA binding, preventing lipogenic gene expression PMID:11724780.
Traditional view: AMPK → inhibits mTOR → activates autophagy
New evidence: AMPK may actually suppress autophagy under certain conditions, particularly amino acid starvation. This represents a major shift in understanding [Web search findings 2024].
2024 research identified PRKAA2-specific functions in photoreceptor neurons involving IMPDH (inosine monophosphate dehydrogenase) regulation, representing novel therapeutic targets.
AMPK α2 responds to:
1. AMP:ATP ratio changes: Primary activation mechanism
2. Upstream kinases: LKB1 complex PMID:14511394
3. Calcium signaling: [PMID:25788287 studies show calcium-dependent activation]
4. Pharmacological activators: Caffeine PMID:19608206, AICAR, metformin
AMPK functions as a heterotrimeric complex:
- α subunit (catalytic): PRKAA1 or PRKAA2
- β subunit (regulatory): bridges α and γ subunits PMID:15695819
- γ subunit (regulatory): contains CBS domains for AMP/ATP binding
Strong Evidence (Accept):
- Kinase activities (AMP-activated, serine/threonine)
- ATP/nucleotide binding
- Fatty acid metabolic processes
- Energy homeostasis
- Glucose homeostasis
Context-Dependent (Mark as Non-Core):
- Autophagy regulation (complex, bidirectional)
- Circadian rhythm regulation
- Cellular responses to specific stimuli
Likely Over-Annotations (Consider Removal):
- Chromatin remodeling (likely indirect)
- Wnt signaling (likely indirect)
- Steroid biosynthesis (should be "negative regulation")
- Histone H2BS36 kinase activity (overly specific without strong rat evidence)
This analysis synthesized:
- Experimental papers cited in existing GO annotations
- Recent literature (2020-2024) from web searches
- Established reviews and comprehensive studies
- Tissue-specific functional studies
Evidence Quality Assessment:
- Direct biochemical evidence > Genetic evidence > Computational predictions
- In vivo studies > In vitro studies > Cell culture
- Multiple independent studies > Single study findings
Issue: Validation failure due to 25 annotations with GO_REF:0000096 reference that no longer exist in the current GOA file.
Root Cause: The reference GO_REF:0000096 ("Automated transfer of experimentally-verified manual GO annotation data to mouse-rat orthologs") has been retired from the GOA annotation pipeline and replaced with other reference systems like GO_REF:0000121.
Action Taken: Marked all 27 annotations with original_reference_id: GO_REF:0000096 as retired: true to exclude them from GOA validation while preserving the annotation review work.
Annotations Affected: All annotations with ISO evidence type using GO_REF:0000096, including:
- GO:0031669 (cellular response to nutrient levels)
- GO:0004679 (AMP-activated protein kinase activity)
- GO:0004674 (protein serine/threonine kinase activity)
- GO:0140823 (histone H2BS36 kinase activity)
- GO:0042149 (cellular response to glucose starvation)
- Multiple other metabolic and regulatory terms
Validation Status: After marking these annotations as retired, the gene should pass GOA validation checks since retired annotations are now excluded from validation.
Note: These annotations represent legitimate functional information that was previously transferred from experimentally verified mouse/human data. The retirement only reflects changes in the GOA annotation pipeline, not changes in the underlying biology.
Exported on March 22, 2026 at 12:59 AM
Organism: Rattus norvegicus
Sequence:
MAEKQKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEVEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDMAMHIPPGLKPHPERMPPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLVDNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSVDSSTAENHSLSGSLTGSLTGSTLSSASPRLGSHTMDFFEMCASLITALAR
I begin with the InterPro architecture. The N-terminal catalytic core is defined by IPR000719 (Protein kinase domain, residues 16–268) embedded within IPR011009 (Protein kinase-like domain superfamily, residues 13–269). Within this core lie IPR017441 (Protein kinase, ATP binding site, residues 22–45) and IPR008271 (Serine/threonine-protein kinase, active site, residues 135–147). This tightly clustered arrangement establishes a bilobal serine/threonine kinase engine that binds ATP and transfers phosphate to Ser/Thr residues—chemistry that directly yields GO:0005524 ATP binding and GO:0004674 protein serine/threonine kinase activity. Immediately C-terminal to the kinase core, two overlapping autoinhibitory modules—IPR028783 (PRKAA2, UBA-like autoinhibitory domain, residues 285–349) and IPR049020 (PRKAA1/2 autoinhibitory domain, residues 288–333)—precede a regulatory tail that specializes this enzyme’s behavior. This tail is characteristic of AMPK catalytic subunits and comprises IPR039148 (5'-AMP-activated protein kinase catalytic subunit alpha-2, C-terminal, residues 395–550), IPR032270 (AMPK, C-terminal adenylate sensor domain, residues 401–479), and IPR028375 (KA1 domain/Ssp2, C-terminal homologous superfamily, residues 402–552). The ordered layout—kinase core → autoinhibitory segment → adenylate-sensing and KA1-bearing C-terminus—creates an allosterically regulated kinase whose activity is tuned by adenylate nucleotides and whose C-terminal module mediates nucleic-acid/protein interactions and assembly.
This architecture causes a specific molecular function profile. The canonical kinase domain and active-site signatures specify serine/threonine phosphorylation of diverse substrates (GO:0004674), while the ATP-binding pocket supports nucleotide handling (GO:0005524). The autoinhibitory module enforces basal suppression and requires upstream phosphorylation to relieve inhibition, a hallmark of energy-sensing kinases. The adenylate sensor domain and KA1-bearing tail couple catalytic output to cellular energy status and macromolecular targeting, explaining how this kinase coordinates phosphorylation with adenylate availability.
From this molecular function, the biological process follows. An adenylate-tuned serine/threonine kinase that targets metabolic and cytoskeletal regulators will drive energy-stress signaling and metabolic remodeling. Phosphorylation of metabolic hubs and cytoskeletal elements logically feeds into energy homeostasis and cytoskeletal organization; thus the most defensible process umbrella is signal transduction feeding into energy-coupled pathways (GO:0007165 signal transduction) that modulate broader cellular economy.
Cellular location is inferred from soluble kinase architecture lacking transmembrane segments and from targeting motifs typical of AMPK catalytic subunits. The soluble catalytic fold, together with KA1/C-terminal modules that mediate chromatin and nucleic-acid interactions, supports a predominantly cytoplasmic residence with regulated access to the nucleus. This reasoning aligns with a cytoplasmic localization and accommodates dynamic nucleo-cytoplasmic shuttling (GO:0005737 cytoplasm).
Mechanistically, the kinase core is held inactive by the autoinhibitory region; activation proceeds via phosphorylation of the activation loop and subsequent assembly with adenylate-tuned regulatory partners. The C-terminal adenylate sensor and KA1 domain position the enzyme to respond to AMP/ADP levels and to dock onto macromolecular scaffolds. I therefore hypothesize that this kinase forms a heterotrimeric energy-sensing complex with regulatory subunits and nucleic-acid-associated adaptors, phosphorylating cytoskeletal and metabolic substrates to enforce energy-coupled control. Likely interaction partners include AMPK regulatory β and γ subunits that complete the energy-sensing holoenzyme, upstream activating kinases that deliver activating phosphorylation, and downstream cytoskeletal and metabolic targets that execute the program.
A soluble energy-regulated serine/threonine kinase that uses an N-terminal catalytic core and a C-terminal adenylate-responsive module to phosphorylate metabolic and cytoskeletal substrates. Autoinhibitory elements restrain basal activity until relief by upstream phosphorylation and adenylate sensing. Operating primarily in the cytoplasm with regulated access to the nucleus, it coordinates energy-stress signaling and broader cellular economy by coupling nucleotide sensing to substrate phosphorylation.
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in energy homeostasis.
IPR011009, homologous_superfamily) — residues 13-269IPR000719, domain) — residues 16-268IPR017441, binding_site) — residues 22-45IPR008271, active_site) — residues 135-147IPR028783, domain) — residues 285-349IPR049020, domain) — residues 288-333IPR039148, domain) — residues 395-550IPR032270, domain) — residues 401-479IPR028375, homologous_superfamily) — residues 402-552Molecular Function: molecular_function (GO:0003674), catalytic activity (GO:0003824), binding (GO:0005488), molecular adaptor activity (GO:0060090), small molecule binding (GO:0036094), protein-macromolecule adaptor activity (GO:0030674), organic cyclic compound binding (GO:0097159), transferase activity (GO:0016740), heterocyclic compound binding (GO:1901363), protein-containing complex binding (GO:0044877), ion binding (GO:0043167), catalytic activity, acting on a protein (GO:0140096), carbohydrate derivative binding (GO:0097367), protein binding (GO:0005515), nucleoside phosphate binding (GO:1901265), protein kinase activity (GO:0004672), anion binding (GO:0043168), transferase activity, transferring phosphorus-containing groups (GO:0016772), nucleotide binding (GO:0000166), ribonucleotide binding (GO:0032553), protein serine/threonine kinase activity (GO:0004674), kinase activity (GO:0016301), phosphotransferase activity, alcohol group as acceptor (GO:0016773), purine nucleotide binding (GO:0017076), purine ribonucleoside triphosphate binding (GO:0035639), purine ribonucleotide binding (GO:0032555), ATP binding (GO:0005524), adenyl ribonucleotide binding (GO:0032559), AMP-activated protein kinase activity (GO:0004679), adenyl nucleotide binding (GO:0030554)
Biological Process: biological_process (GO:0008150), metabolic process (GO:0008152), positive regulation of biological process (GO:0048518), regulation of biological process (GO:0050789), homeostatic process (GO:0042592), multicellular organismal process (GO:0032501), biological regulation (GO:0065007), response to stimulus (GO:0050896), cellular process (GO:0009987), response to chemical (GO:0042221), regulation of metabolic process (GO:0019222), nitrogen compound metabolic process (GO:0006807), organic substance metabolic process (GO:0071704), response to activity (GO:0014823), multicellular organismal-level homeostasis (GO:0048871), chemical homeostasis (GO:0048878), cellular homeostasis (GO:0019725), cellular metabolic process (GO:0044237), positive regulation of cellular process (GO:0048522), response to endogenous stimulus (GO:0009719), regulation of cellular process (GO:0050794), positive regulation of metabolic process (GO:0009893), cellular response to stimulus (GO:0051716), primary metabolic process (GO:0044238), lipid homeostasis (GO:0055088), organonitrogen compound metabolic process (GO:1901564), positive regulation of carbohydrate metabolic process (GO:0045913), energy homeostasis (GO:0097009), protein metabolic process (GO:0019538), carbohydrate homeostasis (GO:0033500), cellular response to endogenous stimulus (GO:0071495), response to oxygen-containing compound (GO:1901700), macromolecule metabolic process (GO:0043170), response to organic substance (GO:0010033), phosphorus metabolic process (GO:0006793), regulation of catabolic process (GO:0009894), positive regulation of small molecule metabolic process (GO:0062013), intracellular chemical homeostasis (GO:0055082), response to inorganic substance (GO:0010035), response to nitrogen compound (GO:1901698), positive regulation of cellular metabolic process (GO:0031325), cellular response to chemical stimulus (GO:0070887), regulation of small molecule metabolic process (GO:0062012), regulation of nitrogen compound metabolic process (GO:0051171), regulation of cellular metabolic process (GO:0031323), regulation of primary metabolic process (GO:0080090), positive regulation of catabolic process (GO:0009896), response to salt (GO:1902074), positive regulation of nitrogen compound metabolic process (GO:0051173), response to metal ion (GO:0010038), cellular response to organonitrogen compound (GO:0071417), fatty acid homeostasis (GO:0055089), response to carbohydrate (GO:0009743), regulation of carbohydrate catabolic process (GO:0043470), positive regulation of phosphorus metabolic process (GO:0010562), cellular response to organic substance (GO:0071310), cellular response to salt (GO:1902075), cellular response to nitrogen compound (GO:1901699), phosphate-containing compound metabolic process (GO:0006796), regulation of carbohydrate metabolic process (GO:0006109), protein modification process (GO:0036211), regulation of nucleotide metabolic process (GO:0006140), positive regulation of nucleobase-containing compound metabolic process (GO:0045935), response to calcium ion (GO:0051592), regulation of generation of precursor metabolites and energy (GO:0043467), macromolecule modification (GO:0043412), response to organonitrogen compound (GO:0010243), cellular response to inorganic substance (GO:0071241), positive regulation of glycolytic process (GO:0045821), glucose homeostasis (GO:0042593), positive regulation of nucleotide metabolic process (GO:0045981), regulation of nucleobase-containing compound metabolic process (GO:0019219), positive regulation of cellular catabolic process (GO:0031331), response to organic cyclic compound (GO:0014070), regulation of lipid metabolic process (GO:0019216), regulation of cellular catabolic process (GO:0031329), cellular response to oxygen-containing compound (GO:1901701), intracellular glucose homeostasis (GO:0001678), regulation of phosphorus metabolic process (GO:0051174), regulation of purine nucleotide metabolic process (GO:1900542), response to alkaloid (GO:0043279), regulation of glycolytic process (GO:0006110), cellular response to calcium ion (GO:0071277), positive regulation of phosphate metabolic process (GO:0045937), cellular response to carbohydrate stimulus (GO:0071322), cellular response to glucose stimulus (GO:0071333), protein phosphorylation (GO:0006468), response to monosaccharide (GO:0034284), regulation of phosphate metabolic process (GO:0019220), phosphorylation (GO:0016310), cellular response to metal ion (GO:0071248), positive regulation of purine nucleotide metabolic process (GO:1900544), response to purine-containing compound (GO:0014074), regulation of phosphorylation (GO:0042325), regulation of ATP metabolic process (GO:1903578), cellular response to monosaccharide stimulus (GO:0071326), response to caffeine (GO:0031000), positive regulation of phosphorylation (GO:0042327), response to hexose (GO:0009746), positive regulation of ATP metabolic process (GO:1903580), cellular response to hexose stimulus (GO:0071331), response to glucose (GO:0009749)
Cellular Component: cellular_component (GO:0005575), protein-containing complex (GO:0032991), cellular anatomical entity (GO:0110165), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), cell projection (GO:0042995), membrane (GO:0016020), cell body (GO:0044297), cell periphery (GO:0071944), intracellular protein-containing complex (GO:0140535), apical part of cell (GO:0045177), catalytic complex (GO:1902494), somatodendritic compartment (GO:0036477), cytoplasm (GO:0005737), membrane-enclosed lumen (GO:0031974), nucleoplasm (GO:0005654), transferase complex (GO:1990234), plasma membrane bounded cell projection (GO:0120025), intracellular organelle (GO:0043229), nucleotide-activated protein kinase complex (GO:0031588), apical plasma membrane (GO:0016324), neuronal cell body (GO:0043025), plasma membrane region (GO:0098590), organelle lumen (GO:0043233), dendritic tree (GO:0097447), membrane-bounded organelle (GO:0043227), plasma membrane (GO:0005886), intracellular membrane-bounded organelle (GO:0043231), transferase complex, transferring phosphorus-containing groups (GO:0061695), dendrite (GO:0030425), neuron projection (GO:0043005), intracellular organelle lumen (GO:0070013), nucleus (GO:0005634), protein kinase complex (GO:1902911), nuclear lumen (GO:0031981), axon (GO:0030424)
Generated by BioReason
Source: Prkaa2-bioreason-rl-predictions.md
The functional summary states:
A soluble energy-regulated serine/threonine kinase that uses an N-terminal catalytic core and a C-terminal adenylate-responsive module to phosphorylate metabolic and cytoskeletal substrates. Autoinhibitory elements restrain basal activity until relief by upstream phosphorylation and adenylate sensing. Operating primarily in the cytoplasm with regulated access to the nucleus, it coordinates energy-stress signaling and broader cellular economy by coupling nucleotide sensing to substrate phosphorylation.
This is largely correct and captures the core biology of AMPK alpha-2. The curated review confirms protein serine/threonine kinase activity (GO:0004674), AMP-activated protein kinase activity (GO:0004679), ATP binding (GO:0005524), energy homeostasis functions, and cytoplasm/nucleus localization. The description of the autoinhibitory domain, adenylate sensor, and heterotrimeric complex assembly is well-supported.
One issue: while the summary mentions "metabolic and cytoskeletal substrates," the curated review emphasizes metabolic substrates (ACC, HMGCR, PFK-2, ChREBP, TSC2, Raptor) far more than cytoskeletal targets. The repeated mention of "cytoskeletal" substrates in the summary and thinking trace appears to be driven by the KA1 domain annotation, which BioReason interprets as mediating cytoskeletal interactions. While AMPK does have roles in cell polarity and cytoskeletal regulation, this emphasis slightly overstates what is a secondary function relative to the primary metabolic control role. This is a minor accuracy issue.
The curated review also highlights chromatin remodeling (GO:0006338) via histone H2B phosphorylation, positive regulation of autophagy (GO:0010508), and cellular response to glucose starvation (GO:0042149) -- none of which are mentioned in the BioReason summary. These represent important biology that the domain-based reasoning does not capture.
Comparison with interpro2go:
The interpro2go annotation for Prkaa2 is protein kinase activity (GO:0004672), which the curated review marks for REMOVE as too general. BioReason's summary goes well beyond this, correctly identifying the AMPK-specific context from the autoinhibitory domain (IPR028783/IPR049020) and adenylate sensor domain (IPR032270). The specific AMPK identity is correctly inferred from domain architecture rather than just recapitulating the generic kinase annotation. This represents genuine added value.
The trace provides a thorough domain-by-domain analysis and correctly identifies the AMPK catalytic subunit architecture. The hypothesis about heterotrimeric complex formation with beta and gamma subunits is accurate. The overemphasis on cytoskeletal substrates appears to stem from over-interpreting the KA1 domain's function. The KA1 domain in AMPK alpha subunits primarily mediates membrane/lipid association and scaffold interactions rather than direct cytoskeletal targeting.
id: Q09137
gene_symbol: Prkaa2
taxon:
id: NCBITaxon:10116
label: Rattus norvegicus
description: PRKAA2 encodes the alpha-2 catalytic subunit of AMP-activated
protein kinase (AMPK), a central cellular energy sensor that maintains energy
homeostasis. As a serine/threonine kinase, PRKAA2 is activated when cellular
AMP/ATP ratios rise, triggering phosphorylation of metabolic enzymes to
suppress anabolic processes (fatty acid/cholesterol synthesis) while promoting
catabolic processes (fatty acid oxidation, glycolysis, autophagy). The protein
forms heterotrimeric complexes with regulatory beta and gamma subunits,
localizes to both cytoplasm and nucleus, and phosphorylates key substrates
including ACC (fatty acid synthesis), HMGCR (cholesterol synthesis), PFK-2
(glycolysis), and ChREBP (transcriptional regulation). Recent discoveries
highlight its direct role in chromatin remodeling via histone H2B
phosphorylation under stress conditions.
existing_annotations:
- term:
id: GO:0004674
label: protein serine/threonine kinase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Core catalytic function strongly supported by extensive
biochemical evidence. PRKAA2 phosphorylates serine/threonine residues on
numerous substrates (ACC, HMGCR, PFK-2, ChREBP, TSC2, Raptor). Multiple
IDA studies confirm this activity (PMID:8955377, PMID:12065578).
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research.md
supporting_text: Generated using OpenAI Deep Research API
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
Prkaa2 encodes a **protein kinase** (EC 2.7.11.1; Ser/Thr kinase).
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Well-established function through ULK1 phosphorylation and mTORC1
inhibition. However, 2024 research shows complexity - AMPK can suppress
autophagy in specific contexts. Keep as important but context-dependent
function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0042149
label: cellular response to glucose starvation
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Core function - AMPK is the primary cellular glucose/energy
sensor. Activated by low glucose via AMP/ATP ratio changes. Knockout
mice show impaired glucose homeostasis. Multiple ISS/ISO annotations
support this.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation.
- term:
id: GO:0006338
label: chromatin remodeling
evidence_type: IEA
original_reference_id: GO_REF:0000108
review:
summary: Supported by evidence that AMPK/PRKAA2 phosphorylates histone H2B
under metabolic stress, linking energy sensing to chromatin remodeling.
action: ACCEPT
reason: Chromatin remodeling is supported by histone H2B Ser36
phosphorylation in stress conditions, aligning with core_functions that
capture this epigenetic regulation.
- term:
id: GO:0004672
label: protein kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Too general - more specific terms available (serine/threonine
kinase, AMP-activated protein kinase). Redundant with better-annotated
specific terms.
action: REMOVE
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Core defining function of PRKAA2. Multiple IDA studies confirm
(PMID:11069105, PMID:11724780, PMID:14511394). This is THE primary
molecular function.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation.
- term:
id: GO:0005524
label: ATP binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Essential for kinase function - ATP is the phosphate donor. IDA
evidence exists (PMID:16648175). Crystal structures confirm ATP-binding
pocket.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
The α subunit provides the **catalytic kinase activity** and is activated primarily by phosphorylation at a conserved threonine within the activation loop (**Thr172 for α2**), which is a core mechanistic definition of “AMPK activation.”
- term:
id: GO:0000166
label: nucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too general - ATP binding is more specific and already annotated.
Redundant.
action: REMOVE
- term:
id: GO:0004674
label: protein serine/threonine kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Automated annotation consistent with IBA and IDA evidence. Core
kinase function.
action: ACCEPT
- term:
id: GO:0006325
label: chromatin organization
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Weak IEA evidence. While H2B phosphorylation occurs, this is
stress-specific and not a primary function. Too broad.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0006629
label: lipid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Core function via ACC and HMGCR phosphorylation. Controls fatty
acid and cholesterol synthesis. Strong experimental support
(PMID:12065578). However, more specific terms available.
action: ACCEPT
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Core function - directly regulates ACC to control fatty acid
synthesis/oxidation balance. IDA evidence for fatty acid homeostasis
(PMID:11724780).
action: ACCEPT
- term:
id: GO:0006633
label: fatty acid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: AMPK actually INHIBITS fatty acid synthesis by phosphorylating
ACC. This annotation implies positive regulation which is incorrect.
action: REMOVE
- term:
id: GO:0006694
label: steroid biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too broad and AMPK generally inhibits steroid/cholesterol
synthesis. More specific negative regulation terms would be appropriate.
action: REMOVE
- term:
id: GO:0006695
label: cholesterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: AMPK INHIBITS cholesterol synthesis via HMGCR phosphorylation.
This term implies positive regulation which is incorrect.
action: REMOVE
- term:
id: GO:0006914
label: autophagy
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too broad - 'positive regulation of autophagy' is more accurate.
Complex bidirectional regulation discovered in 2024.
action: REMOVE
- term:
id: GO:0008202
label: steroid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too broad. AMPK's role is more specific to cholesterol metabolism
inhibition.
action: REMOVE
- term:
id: GO:0008203
label: cholesterol metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: AMPK regulates cholesterol metabolism primarily through HMGCR
inhibition. Keep but note the regulatory direction.
action: ACCEPT
reason: PRKAA2 directly phosphorylates and inhibits HMGCR, making
cholesterol metabolism a core regulated process in energy stress.
- term:
id: GO:0016055
label: Wnt signaling pathway
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Weak evidence, likely indirect effect. May phosphorylate
beta-catenin but not a primary function. IEA only.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0016126
label: sterol biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: AMPK inhibits rather than promotes sterol synthesis. Misleading
annotation.
action: REMOVE
- term:
id: GO:0016301
label: kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too general - more specific terms (protein serine/threonine
kinase, AMP-activated protein kinase) are already annotated.
action: REMOVE
- term:
id: GO:0016740
label: transferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Far too general - specific kinase terms already present. No value
added.
action: REMOVE
- term:
id: GO:0031000
label: response to caffeine
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: IDA evidence exists (PMID:19608206) showing caffeine activates
AMPK in muscle. However, this is a pharmacological response, not a core
function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0045821
label: positive regulation of glycolytic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Core function - AMPK phosphorylates PFK-2 at Ser466 to activate
glycolysis. Strong IDA evidence (PMID:11069105). Critical for ATP
generation under stress.
action: ACCEPT
- term:
id: GO:0046872
label: metal ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Mg2+ binding is required for kinase activity (coordinates ATP).
Standard feature of protein kinases. Could be more specific.
action: MODIFY
proposed_replacement_terms:
- id: GO:0000287
label: magnesium ion binding
- term:
id: GO:0047322
label: '[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity'
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Specific substrate phosphorylation well-documented
(PMID:2369897). Important for cholesterol homeostasis. Keep as it
provides mechanistic specificity.
action: ACCEPT
- term:
id: GO:0048511
label: rhythmic process
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Too vague. 'Regulation of circadian rhythm' is more specific and
has better evidence. Redundant.
action: REMOVE
- term:
id: GO:0055089
label: fatty acid homeostasis
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Core function with strong IDA evidence (PMID:11724780). AMPK
balances fatty acid synthesis/oxidation via ACC phosphorylation.
action: ACCEPT
- term:
id: GO:0071277
label: cellular response to calcium ion
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: AMPK is activated by CaMKK2 in response to calcium. IMP evidence
exists (PMID:25788287). Important regulatory mechanism but not primary
function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071333
label: cellular response to glucose stimulus
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Core function - responds to both high and low glucose. IMP
evidence (PMID:25788287). Central to glucose homeostasis.
action: ACCEPT
- term:
id: GO:0097009
label: energy homeostasis
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: THE core function of AMPK - master regulator of cellular energy
balance. Strong IDA evidence (PMID:11724780). Fundamental role.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
Functionally, AMPKα2 integrates energy stress to inhibit anabolic metabolism and promote catabolism and autophagy
- term:
id: GO:0106310
label: protein serine kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
review:
summary: Redundant with 'protein serine/threonine kinase activity' which
is more complete and has better evidence.
action: REMOVE
- term:
id: GO:0031669
label: cellular response to nutrient levels
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Core function - AMPK senses and responds to nutrient
availability. Strong ISO evidence from mouse. Fundamental role in
metabolism. RETIRED - GO_REF:0000096 no longer used in GOA.
action: ACCEPT
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Duplicate annotation - core AMPK function already reviewed as IBA
evidence type. This ISO annotation provides additional ortholog-based
support for the same function. RETIRED - GO_REF:0000096 no longer used
in GOA.
action: ACCEPT
- term:
id: GO:0004674
label: protein serine/threonine kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog-based annotation consistent with IBA and IDA evidence.
Core kinase function. RETIRED - GO_REF:0000096 no longer used in GOA.
action: ACCEPT
- term:
id: GO:0140823
label: histone H2BS36 kinase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Evidence for H2B Ser36 phosphorylation by AMPK under stress
conditions is well-established in mammals. This is a specific
stress-response function supported by experimental data.
action: ACCEPT
- term:
id: GO:0140823
label: histone H2BS36 kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for H2B Ser36 phosphorylation under stress
conditions.
action: ACCEPT
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Strong evidence - PMID:25788287 shows calcium-dependent AMPK
activation in neurons. IMP evidence for core AMPK function.
action: ACCEPT
supported_by:
- reference_id: PMID:25788287
supporting_text: Polarized activities of AMPK and BRSK in primary
hippocampal neurons
- term:
id: GO:0042149
label: cellular response to glucose starvation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Sequence similarity evidence for glucose starvation response.
Core AMPK function.
action: ACCEPT
- term:
id: GO:0042149
label: cellular response to glucose starvation
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for glucose starvation response. Core AMPK
function.
action: ACCEPT
- term:
id: GO:1905691
label: lipid droplet disassembly
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: AMPK promotes lipolysis and lipid droplet breakdown via
phosphorylation of lipases and metabolic enzymes. This is supported by
evidence of AMPK activating lipid oxidation pathways.
action: KEEP_AS_NON_CORE
- term:
id: GO:1905691
label: lipid droplet disassembly
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for AMPK role in lipid droplet breakdown.
action: KEEP_AS_NON_CORE
- term:
id: GO:0062028
label: regulation of stress granule assembly
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: AMPK responds to stress conditions and may influence stress
granule formation, but evidence is indirect. Likely over-annotation as
not a primary function.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0010629
label: negative regulation of gene expression
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: AMPK negatively regulates lipogenic genes (ChREBP, SREBP) and
anabolic gene programs. However, term is too broad - more specific terms
would be better.
action: KEEP_AS_NON_CORE
- term:
id: GO:0034599
label: cellular response to oxidative stress
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: AMPK is activated during oxidative stress and promotes protective
responses including autophagy. This is a legitimate stress response
function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0070507
label: regulation of microtubule cytoskeleton organization
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Weak evidence - AMPK may indirectly affect cytoskeleton but this
is not a well-established primary function. Likely over-annotation.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0071277
label: cellular response to calcium ion
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for calcium-dependent AMPK activation.
Important regulatory mechanism.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071277
label: cellular response to calcium ion
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Strong evidence - PMID:25788287 demonstrates calcium-dependent
AMPK activation via CaMKK2 pathway. Important regulatory mechanism but
not core metabolic function.
action: KEEP_AS_NON_CORE
supported_by:
- reference_id: PMID:25788287
supporting_text: 2015 Mar 18. Polarized activities of AMPK and BRSK in
primary hippocampal neurons.
- term:
id: GO:0071333
label: cellular response to glucose stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for glucose response. Core AMPK function.
action: ACCEPT
- term:
id: GO:0071333
label: cellular response to glucose stimulus
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Strong supporting evidence for core glucose sensing function. IMP
evidence adds to already accepted IEA annotation.
action: ACCEPT
supported_by:
- reference_id: PMID:25788287
supporting_text: Polarized activities of AMPK and BRSK in primary
hippocampal neurons
- term:
id: GO:0010468
label: regulation of gene expression
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Too broad - AMPK regulates specific gene sets via ChREBP, SREBP,
p53, etc. More specific terms would be preferable.
action: KEEP_AS_NON_CORE
- term:
id: GO:0014850
label: response to muscle activity
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Well-established function - AMPK is activated during muscle
contraction and exercise. Important for muscle energy metabolism
adaptation.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071466
label: cellular response to xenobiotic stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: AMPK can be activated by xenobiotics like AICAR, metformin, and
other compounds. Secondary response, not core function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0016241
label: regulation of macroautophagy
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: More specific than general autophagy term. AMPK regulates
macroautophagy via ULK1 phosphorylation and mTORC1 inhibition.
Established function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0016241
label: regulation of macroautophagy
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for macroautophagy regulation. Established
function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071380
label: cellular response to prostaglandin E stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Very specific response that may occur but is not well-documented
as primary function. Likely over-annotation.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0004712
label: protein serine/threonine/tyrosine kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: AMPK is primarily serine/threonine kinase, not tyrosine. This
broader term is less accurate than the specific serine/threonine kinase
annotation.
action: REMOVE
- term:
id: GO:0003682
label: chromatin binding
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: AMPK translocates to nucleus under stress and binds chromatin to
phosphorylate histones. Evidence from H2B phosphorylation studies
supports this.
action: KEEP_AS_NON_CORE
- term:
id: GO:0003682
label: chromatin binding
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for chromatin binding during stress responses.
action: KEEP_AS_NON_CORE
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IDA
original_reference_id: PMID:11069105
review:
summary: Strong direct evidence for core AMPK function. PMID:11069105
demonstrates AMPK phosphorylation of PFK-2, confirming kinase activity.
action: ACCEPT
supported_by:
- reference_id: PMID:11069105
supporting_text: Phosphorylation and activation of heart PFK-2 by AMPK
has a role in the stimulation of glycolysis during ischaemia
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IDA
original_reference_id: PMID:11724780
review:
summary: Strong direct evidence for core AMPK function. PMID:11724780
demonstrates AMPK phosphorylation of ChREBP, confirming kinase activity.
action: ACCEPT
supported_by:
- reference_id: PMID:11724780
supporting_text: 'Mechanism for fatty acid "sparing" effect on glucose-induced
transcription: regulation of carbohydrate-responsive element-binding protein
by AMP-activated protein kinase'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11069105
review:
summary: Too general - AMPK binds many proteins but more specific terms
would be better (complex binding, substrate binding). Remove as
uninformative.
action: REMOVE
supported_by:
- reference_id: PMID:11069105
supporting_text: Phosphorylation and activation of heart PFK-2 by AMPK
has a role in the stimulation of glycolysis during ischaemia.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:11724780
review:
summary: Too general - AMPK binds many proteins but more specific terms
would be better. Remove as uninformative.
action: REMOVE
supported_by:
- reference_id: PMID:11724780
supporting_text: 'Nov 27. Mechanism for fatty acid "sparing" effect on glucose-induced
transcription: regulation of carbohydrate-responsive element-binding protein
by AMP-activated protein kinase.'
- term:
id: GO:0008610
label: lipid biosynthetic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Misleading - AMPK actually INHIBITS lipid biosynthesis by
phosphorylating ACC and other enzymes. This should be negative
regulation.
action: REMOVE
- term:
id: GO:0008610
label: lipid biosynthetic process
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Misleading - AMPK actually INHIBITS lipid biosynthesis. Remove
incorrect annotation.
action: REMOVE
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Sequence similarity evidence for autophagy regulation. Complex
context-dependent function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for autophagy regulation. Complex
context-dependent function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0031669
label: cellular response to nutrient levels
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Sequence similarity evidence for nutrient sensing. Core AMPK
function.
action: ACCEPT
- term:
id: GO:0032007
label: negative regulation of TOR signaling
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Core function - AMPK inhibits mTORC1 via TSC2 and Raptor
phosphorylation. Well-established mechanism for energy conservation.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
- term:
id: GO:0032007
label: negative regulation of TOR signaling
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for TOR inhibition. Core metabolic regulation.
action: ACCEPT
- term:
id: GO:0042752
label: regulation of circadian rhythm
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: AMPK phosphorylates CRY1 and links metabolism to circadian
rhythms. However, this is not a primary metabolic function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0042752
label: regulation of circadian rhythm
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for circadian regulation via CRY1
phosphorylation.
action: KEEP_AS_NON_CORE
- term:
id: GO:0043066
label: negative regulation of apoptotic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: AMPK can promote cell survival during mild stress via autophagy
and p53 phosphorylation. Context-dependent protective function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0043066
label: negative regulation of apoptotic process
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for cell survival promotion during stress.
action: KEEP_AS_NON_CORE
- term:
id: GO:0045821
label: positive regulation of glycolytic process
evidence_type: IDA
original_reference_id: PMID:11069105
review:
summary: Strong direct evidence - PMID:11069105 demonstrates AMPK
phosphorylation of PFK-2 which activates glycolysis. Core metabolic
function.
action: ACCEPT
supported_by:
- reference_id: PMID:11069105
supporting_text: Phosphorylation and activation of heart PFK-2 by AMPK
has a role in the stimulation of glycolysis during ischaemia
- term:
id: GO:0055089
label: fatty acid homeostasis
evidence_type: IDA
original_reference_id: PMID:11724780
review:
summary: Strong direct evidence - PMID:11724780 shows AMPK regulation of
fatty acid metabolism via ACC phosphorylation. Core function already
accepted from IEA.
action: ACCEPT
supported_by:
- reference_id: PMID:11724780
supporting_text: 'Mechanism for fatty acid "sparing" effect on glucose-induced
transcription: regulation of carbohydrate-responsive element-binding protein
by AMP-activated protein kinase'
- term:
id: GO:0097009
label: energy homeostasis
evidence_type: IDA
original_reference_id: PMID:11724780
review:
summary: Strong direct evidence - PMID:11724780 demonstrates AMPK role in
cellular energy balance. THE core function already accepted from IEA.
action: ACCEPT
supported_by:
- reference_id: PMID:11724780
supporting_text: 'Mechanism for fatty acid "sparing" effect on glucose-induced
transcription: regulation of carbohydrate-responsive element-binding protein
by AMP-activated protein kinase'
- term:
id: GO:0042593
label: glucose homeostasis
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Core function - AMPK is central to glucose homeostasis through
multiple mechanisms. Well-established role in glucose metabolism.
action: ACCEPT
- term:
id: GO:0042593
label: glucose homeostasis
evidence_type: ISO
original_reference_id: GO_REF:0000096
retired: true
review:
summary: Ortholog evidence for glucose homeostasis. Core metabolic
function.
action: ACCEPT
- term:
id: GO:0014823
label: response to activity
evidence_type: IDA
original_reference_id: PMID:17253964
review:
summary: PMID:17253964 shows adrenergic activation of AMPK in adipocytes
during activity. Important physiological response but not core function.
action: KEEP_AS_NON_CORE
supported_by:
- reference_id: PMID:17253964
supporting_text: Adrenaline is a critical mediator of acute
exercise-induced AMP-activated protein kinase activation in
adipocytes.
- term:
id: GO:0031000
label: response to caffeine
evidence_type: IDA
original_reference_id: PMID:19608206
review:
summary: Strong direct evidence - PMID:19608206 shows caffeine activates
AMPK in skeletal muscle. Pharmacological response already accepted from
IEA.
action: KEEP_AS_NON_CORE
supported_by:
- reference_id: PMID:19608206
supporting_text: 2009 Jul 15. Caffeine acutely activates 5'adenosine
monophosphate-activated protein kinase and increases
insulin-independent glucose transport in rat skeletal muscles.
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IDA
original_reference_id: PMID:14511394
review:
summary: Strong direct evidence - PMID:14511394 demonstrates AMPK
complexes and upstream kinase LKB1. Direct confirmation of kinase
activity.
action: ACCEPT
supported_by:
- reference_id: PMID:14511394
supporting_text: Complexes between the LKB1 tumor suppressor, STRAD
alpha/beta and MO25 alpha/beta are upstream kinases in the
AMP-activated protein kinase cascade
- term:
id: GO:0044877
label: protein-containing complex binding
evidence_type: IDA
original_reference_id: PMID:14511394
review:
summary: PMID:14511394 shows AMPK interaction with LKB1-STRD-MO25 complex.
Specific complex binding is more informative than general protein
binding.
action: KEEP_AS_NON_CORE
supported_by:
- reference_id: PMID:14511394
supporting_text: Complexes between the LKB1 tumor suppressor, STRAD
alpha/beta and MO25 alpha/beta are upstream kinases in the
AMP-activated protein kinase cascade.
- term:
id: GO:0004674
label: protein serine/threonine kinase activity
evidence_type: IDA
original_reference_id: PMID:8955377
review:
summary: Strong direct evidence - PMID:8955377 demonstrates substrate
specificity differences between α1 and α2 isoforms. Core kinase
function.
action: ACCEPT
supported_by:
- reference_id: PMID:8955377
supporting_text: The alpha1 and alpha2 isoforms of the AMP-activated
protein kinase have similar activities in rat liver but exhibit
differences in substrate specificity in vitro.
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IMP
original_reference_id: PMID:10698692
review:
summary: IMP evidence from γ subunit characterization study. Shows
requirement for γ subunit in AMP binding and AMPK activation.
action: ACCEPT
supported_by:
- reference_id: PMID:10698692
supporting_text: Characterization of AMP-activated protein kinase
gamma-subunit isoforms and their role in AMP binding
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IMP
original_reference_id: PMID:8955377
review:
summary: IMP evidence showing differential properties of α2 vs α1
complexes. Demonstrates AMP-activation specifically.
action: ACCEPT
supported_by:
- reference_id: PMID:8955377
supporting_text: The alpha1 and alpha2 isoforms of the AMP-activated
protein kinase have similar activities in rat liver but exhibit
differences in substrate specificity in vitro.
- term:
id: GO:0030674
label: protein-macromolecule adaptor activity
evidence_type: IDA
original_reference_id: PMID:15695819
review:
summary: PMID:15695819 shows β subunit tethering α and γ subunits.
However, this refers to β subunit function, not α2 directly.
action: REMOVE
supported_by:
- reference_id: PMID:15695819
supporting_text: 2005 Jan 28. AMP-activated protein kinase beta
subunit tethers alpha and gamma subunits via its C-terminal sequence
(186-270).
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: IDA
original_reference_id: PMID:16648175
review:
summary: Strong direct evidence - PMID:16648175 shows AMPK activation in
ischemic heart. Direct biochemical demonstration of kinase activity.
action: ACCEPT
supported_by:
- reference_id: PMID:16648175
supporting_text: Activation of AMPK alpha- and gamma-isoform complexes
in the intact ischemic rat heart
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16648175
review:
summary: Too general - while AMPK binds proteins, more specific terms are
preferable. Remove as uninformative.
action: REMOVE
supported_by:
- reference_id: PMID:16648175
supporting_text: Activation of AMPK alpha- and gamma-isoform complexes
in the intact ischemic rat heart.
- term:
id: GO:0005524
label: ATP binding
evidence_type: IDA
original_reference_id: PMID:16648175
review:
summary: Strong evidence - PMID:16648175 demonstrates ATP requirement for
AMPK activity. Core function already accepted from IEA.
action: ACCEPT
supported_by:
- reference_id: PMID:16648175
supporting_text: Activation of AMPK alpha- and gamma-isoform complexes
in the intact ischemic rat heart
- term:
id: GO:0004672
label: protein kinase activity
evidence_type: IDA
original_reference_id: PMID:12065578
review:
summary: Too general - more specific serine/threonine and AMP-activated
kinase terms already accepted. Remove redundant broad term.
action: REMOVE
supported_by:
- reference_id: PMID:12065578
supporting_text: 2002 Jun 13. Coordinate regulation of malonyl-CoA
decarboxylase, sn-glycerol-3-phosphate acyltransferase, and
acetyl-CoA carboxylase by AMP-activated protein kinase in rat
tissues in response to exercise.
- term:
id: GO:0019216
label: regulation of lipid metabolic process
evidence_type: IDA
original_reference_id: PMID:12065578
review:
summary: Strong evidence - PMID:12065578 shows AMPK regulation of ACC and
other lipid metabolic enzymes. Well-established function.
action: ACCEPT
supported_by:
- reference_id: PMID:12065578
supporting_text: Coordinate regulation of malonyl-CoA decarboxylase,
sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase
by AMP-activated protein kinase in rat tissues in response to
exercise
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: AMPK localizes to both cytoplasm and nucleus depending on
cellular conditions. Nuclear localization is particularly important for
its histone H2B phosphorylation function and direct transcriptional
regulation under stress conditions. The α2 subunit can translocate to
nucleus where it phosphorylates chromatin targets and interacts with
transcriptional machinery.
action: ACCEPT
reason: Nuclear localization is essential for AMPK's stress-responsive
chromatin modifying activities and direct transcriptional regulation,
representing a key aspect of its energy-sensing function beyond
cytoplasmic metabolism.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: The cytoplasm is the primary location for AMPK's core metabolic
regulatory functions. Here AMPK phosphorylates key metabolic enzymes
including ACC (fatty acid synthesis), PFK-2 (glycolysis), HMGCR
(cholesterol synthesis), and TSC2/Raptor (mTORC1 signaling). The
majority of AMPK's energy-sensing and metabolic control activities occur
in this compartment.
action: ACCEPT
reason: Cytoplasmic localization is fundamental to AMPK's primary role as
a metabolic energy sensor. Most of its well-characterized substrate
phosphorylation events occur in the cytoplasm where metabolic enzymes
and signaling complexes are located.
- term:
id: GO:1904262
label: negative regulation of TORC1 signaling
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: AMPK directly inhibits mTORC1 by phosphorylating TSC2 and Raptor,
a well-established energy-conservation mechanism. This TORC1-specific
term is more precise than the generic negative regulation of TOR
signaling annotation and reflects a core downstream signaling role.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
- term:
id: GO:1990044
label: protein localization to lipid droplet
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0031588
label: nucleotide-activated protein kinase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Automated annotation consistent with experimental evidence.
Nuclear localization supports stress-responsive functions including
histone phosphorylation and transcriptional regulation.
action: ACCEPT
reason: Supports the manually curated IBA annotation with additional
automated evidence for nuclear localization.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Automated annotation consistent with experimental evidence.
Cytoplasmic localization is where AMPK performs most of its metabolic
regulatory functions through substrate phosphorylation.
action: ACCEPT
reason: Supports the manually curated IBA annotation with additional
automated evidence for cytoplasmic localization.
- term:
id: GO:0030424
label: axon
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0030425
label: dendrite
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0031588
label: nucleotide-activated protein kinase complex
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0043025
label: neuronal cell body
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005634
label: nucleus
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Ortholog-based annotation from mouse-rat comparisons. Nuclear
localization is conserved across mammalian AMPK α2 subunits for
stress-responsive chromatin functions.
action: ACCEPT
reason: Strong orthology evidence supports nuclear localization,
consistent with other annotation types.
- term:
id: GO:0031588
label: nucleotide-activated protein kinase complex
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0031669
label: cellular response to nutrient levels
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0004679
label: AMP-activated protein kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0005829
label: cytosol
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005794
label: Golgi apparatus
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0016607
label: nuclear speck
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0036064
label: ciliary basal body
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:1904262
label: negative regulation of TORC1 signaling
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Sequence-similarity support for AMPK-mediated inhibition of mTORC1
via TSC2/Raptor phosphorylation. Consistent with the curated IBA
annotation for this TORC1-specific term.
action: ACCEPT
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
- term:
id: GO:1904262
label: negative regulation of TORC1 signaling
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Ortholog-based support for AMPK-mediated inhibition of mTORC1.
Consistent with the curated IBA/ISS annotations for this TORC1-specific
term.
action: ACCEPT
- term:
id: GO:0002181
label: cytoplasmic translation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0009267
label: cellular response to starvation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0034198
label: cellular response to amino acid starvation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0038202
label: TORC1 signaling
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0042149
label: cellular response to glucose starvation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0045947
label: negative regulation of translational initiation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0045948
label: positive regulation of translational initiation
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0061462
label: protein localization to lysosome
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0085020
label: protein K6-linked ubiquitination
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:1904263
label: positive regulation of TORC1 signaling
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Direction contradicts AMPK's canonical and well-established role -
AMPKα2 is a negative regulator of mTORC1 (via TSC2/Raptor
phosphorylation), not a positive regulator. This ortholog-transferred
annotation attributes the opposite regulatory direction and is
factually incorrect, not merely imprecise, so it should be removed.
action: REMOVE
supported_by:
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
supporting_text: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
- term:
id: GO:0004674
label: protein serine/threonine kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0140823
label: histone H2BS36 kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:1905691
label: lipid droplet disassembly
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:1990044
label: protein localization to lipid droplet
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:1990044
label: protein localization to lipid droplet
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0006646
label: phosphatidylethanolamine biosynthetic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0006656
label: phosphatidylcholine biosynthetic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0090200
label: positive regulation of release of cytochrome c from mitochondria
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0097284
label: hepatocyte apoptotic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:1903944
label: negative regulation of hepatocyte apoptotic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005737
label: cytoplasm
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Ortholog-based annotation from mouse-rat comparisons. Cytoplasmic
localization is conserved across mammalian AMPK α2 subunits for
metabolic regulatory functions.
action: ACCEPT
reason: Strong orthology evidence supports cytoplasmic localization,
consistent with other annotation types and functional requirements.
- term:
id: GO:0062028
label: regulation of stress granule assembly
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Likely over-annotation; term is too broad for PRKAA2.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0010494
label: cytoplasmic stress granule
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0010629
label: negative regulation of gene expression
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0030424
label: axon
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0030424
label: axon
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:25788287
supporting_text: 2015 Mar 18. Polarized activities of AMPK and BRSK in
primary hippocampal neurons.
- term:
id: GO:0030425
label: dendrite
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0030425
label: dendrite
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:25788287
supporting_text: 2015 Mar 18. Polarized activities of AMPK and BRSK in
primary hippocampal neurons.
- term:
id: GO:0034599
label: cellular response to oxidative stress
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0043025
label: neuronal cell body
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0043025
label: neuronal cell body
evidence_type: IMP
original_reference_id: PMID:25788287
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:25788287
supporting_text: 2015 Mar 18. Polarized activities of AMPK and BRSK in
primary hippocampal neurons.
- term:
id: GO:0070507
label: regulation of microtubule cytoskeleton organization
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Likely over-annotation; term is too broad for PRKAA2.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0071277
label: cellular response to calcium ion
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071333
label: cellular response to glucose stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:1903829
label: positive regulation of protein localization
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0010468
label: regulation of gene expression
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0014850
label: response to muscle activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071466
label: cellular response to xenobiotic stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0016241
label: regulation of macroautophagy
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0071380
label: cellular response to prostaglandin E stimulus
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Likely over-annotation; term is too broad for PRKAA2.
action: MARK_AS_OVER_ANNOTATED
- term:
id: GO:0004712
label: protein serine/threonine/tyrosine kinase activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Annotation is overly general or unsupported in this context and should be removed.
action: REMOVE
- term:
id: GO:0003682
label: chromatin binding
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0008610
label: lipid biosynthetic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Annotation is overly general or unsupported in this context and should be removed.
action: REMOVE
- term:
id: GO:0010508
label: positive regulation of autophagy
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0032007
label: negative regulation of TOR signaling
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0042752
label: regulation of circadian rhythm
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0043066
label: negative regulation of apoptotic process
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: Evidence supports the term but it is not core to PRKAA2 function.
action: KEEP_AS_NON_CORE
- term:
id: GO:0042593
label: glucose homeostasis
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: ISO annotation consistent with curated evidence for this term.
action: ACCEPT
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:18256313
review:
summary: Direct experimental evidence from PMID:18256313 showing AMPK
localization in renal epithelial cells. Cytoplasmic localization is
essential for AMPK's role in controlling glycogen synthase and other
metabolic targets in response to energy stress.
action: ACCEPT
reason: Strong experimental evidence for cytoplasmic localization where
AMPK performs its primary metabolic regulatory functions.
supported_by:
- reference_id: PMID:18256313
supporting_text: Control of glycogen synthase through ADIPOR1-AMPK
pathway in renal distal tubules of normal and diabetic rats.
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IDA
original_reference_id: PMID:18256313
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:18256313
supporting_text: Control of glycogen synthase through ADIPOR1-AMPK
pathway in renal distal tubules of normal and diabetic rats.
- term:
id: GO:0032991
label: protein-containing complex
evidence_type: IDA
original_reference_id: PMID:14511394
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:14511394
supporting_text: Complexes between the LKB1 tumor suppressor, STRAD
alpha/beta and MO25 alpha/beta are upstream kinases in the
AMP-activated protein kinase cascade.
- term:
id: GO:0031588
label: nucleotide-activated protein kinase complex
evidence_type: IDA
original_reference_id: PMID:16648175
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
supported_by:
- reference_id: PMID:16648175
supporting_text: Activation of AMPK alpha- and gamma-isoform complexes
in the intact ischemic rat heart.
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-RNO-164087
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: TAS
original_reference_id: Reactome:R-RNO-164106
review:
summary: Not reviewed in this pass; requires literature review.
action: UNDECIDED
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms.
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data
to orthologs by curator judgment of sequence similarity.
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword
mapping
- id: GO_REF:0000096
title: Automated transfer of experimentally-verified manual GO annotation
data to mouse-rat orthologs.
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on on
inter-ontology links.
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping.
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
- id: PMID:10698692
title: Characterization of AMP-activated protein kinase gamma-subunit
isoforms and their role in AMP binding.
- id: PMID:11069105
title: Phosphorylation and activation of heart PFK-2 by AMPK has a role in
the stimulation of glycolysis during ischaemia.
- id: PMID:11724780
title: 'Mechanism for fatty acid "sparing" effect on glucose-induced transcription:
regulation of carbohydrate-responsive element-binding protein by AMP-activated
protein kinase.'
- id: PMID:12065578
title: Coordinate regulation of malonyl-CoA decarboxylase,
sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by
AMP-activated protein kinase in rat tissues in response to exercise.
- id: PMID:14511394
title: Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and
MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase
cascade.
- id: PMID:15695819
title: AMP-activated protein kinase beta subunit tethers alpha and gamma
subunits via its C-terminal sequence (186-270).
- id: PMID:16648175
title: Activation of AMPK alpha- and gamma-isoform complexes in the intact
ischemic rat heart.
- id: PMID:17253964
title: Adrenaline is a critical mediator of acute exercise-induced
AMP-activated protein kinase activation in adipocytes.
- id: PMID:19608206
title: Caffeine acutely activates 5'adenosine monophosphate-activated
protein kinase and increases insulin-independent glucose transport in rat
skeletal muscles.
- id: PMID:25788287
title: Polarized activities of AMPK and BRSK in primary hippocampal neurons.
- id: PMID:8955377
title: The alpha1 and alpha2 isoforms of the AMP-activated protein kinase
have similar activities in rat liver but exhibit differences in substrate
specificity in vitro.
- id: PMID:2369897
title: 'Regulation of HMG-CoA reductase: identification of the site phosphorylated
by the AMP-activated protein kinase in vitro and in intact rat liver.'
- id: file:rat/Prkaa2/Prkaa2-deep-research.md
title: Deep research synthesis for PRKAA2 functions and regulation
- id: file:rat/Prkaa2/Prkaa2-notes.md
title: Research notes on PRKAA2 with literature citations
- id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
title: Falcon (Edison Scientific) deep research report for rat Prkaa2 (AMPKα2)
findings:
- statement: |-
Prkaa2 encodes the catalytic alpha-2 subunit of the heterotrimeric
AMPK serine/threonine kinase; the alpha subunit carries the catalytic
kinase activity.
supporting_text: |-
AMPK is a **heterotrimeric serine/threonine kinase** consisting of a **catalytic α** subunit plus **regulatory β and γ** subunits.
reference_section_type: OTHER
- statement: |-
The alpha subunit provides the catalytic kinase activity and is
activated by phosphorylation at Thr172 in the activation loop.
supporting_text: |-
The α subunit provides the **catalytic kinase activity** and is activated primarily by phosphorylation at a conserved threonine within the activation loop (**Thr172 for α2**), which is a core mechanistic definition of “AMPK activation.”
reference_section_type: OTHER
- statement: |-
Prkaa2 is a protein serine/threonine kinase (EC 2.7.11.1).
supporting_text: |-
Prkaa2 encodes a **protein kinase** (EC 2.7.11.1; Ser/Thr kinase).
reference_section_type: OTHER
- statement: |-
AMP binding (via the gamma subunit) allosterically activates AMPK and
protects it from dephosphorylation, coupling ATP depletion to kinase
activation — the basis of AMP-activated protein kinase activity.
supporting_text: |-
AMP binding to AMPK (via γ subunit CBS motifs) promotes AMPK activation through allosteric effects and protection from dephosphorylation, coupling ATP depletion to kinase activation.
reference_section_type: OTHER
- statement: |-
Upstream kinases phosphorylate AMPKα2 at Thr172, with LKB1 as a primary
kinase and CaMKKβ/CAMKK2 as a calcium-responsive route.
supporting_text: |-
upstream kinases phosphorylate AMPKα2 at **Thr172**, with **LKB1** frequently highlighted as a primary kinase
reference_section_type: OTHER
- statement: |-
AMPKα2 integrates energy stress to inhibit anabolic metabolism and
promote catabolism and autophagy — its core energy-homeostasis role.
supporting_text: |-
Functionally, AMPKα2 integrates energy stress to inhibit anabolic metabolism and promote catabolism and autophagy
reference_section_type: OTHER
- statement: |-
AMPK phosphorylates metabolic targets including ACC, HMGCR, and
autophagy regulators such as ULK1.
supporting_text: |-
AMPKα2 phosphorylates metabolic targets including ACC/ACAC (canonical readout; ACC Ser79 commonly used), HMGCR, and autophagy regulators such as ULK1
reference_section_type: OTHER
- statement: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor.
supporting_text: |-
AMPK inhibits mTORC1 via phosphorylation of TSC2 and Raptor
reference_section_type: OTHER
- statement: |-
AMPKα2 has a nuclear localization signal and can shuttle to the nucleus,
whereas α1 is primarily cytosolic.
supporting_text: |-
AMPKα2 contains a nuclear localization signal and can shuttle to the nucleus
reference_section_type: OTHER
- statement: |-
A 2024 primary study identifies an AMPKα2-specific role in skeletal
muscle ketone utilization via binding and stabilization of SCOT.
supporting_text: |-
These results place AMPKα2 as an important regulator of **skeletal muscle ketone utilization**
reference_section_type: OTHER
- id: GO_REF:0000121
title: RGD ISO annotations to rat from other mammalian species.
findings: []
- id: PMID:18256313
title: Control of glycogen synthase through ADIPOR1-AMPK pathway in renal
distal tubules of normal and diabetic rats.
findings: []
- id: Reactome:R-RNO-164087
title: Phosphorylation of rChREBP(Ser 568) by rAMPK
findings: []
- id: Reactome:R-RNO-164106
title: rLkb-1 (Stk-11) activates AMPK by phosphorylation
findings: []
core_functions:
- molecular_function:
id: GO:0004679
label: AMP-activated protein kinase activity
directly_involved_in:
- id: GO:0097009
label: energy homeostasis
- id: GO:0055089
label: fatty acid homeostasis
- id: GO:0045821
label: positive regulation of glycolytic process
- id: GO:0042149
label: cellular response to glucose starvation
- id: GO:0032007
label: negative regulation of TOR signaling
locations:
- id: GO:0005737
label: cytoplasm
- id: GO:0005634
label: nucleus
description: PRKAA2 executes ATP-dependent phosphorylation of key metabolic
regulatory proteins in response to cellular AMP/ATP ratio changes. Primary
phosphorylation targets include ACC (inhibiting fatty acid synthesis),
PFK-2 (activating glycolysis), ChREBP (blocking lipogenic transcription),
HMGCR (inhibiting cholesterol synthesis), and TSC2/Raptor (suppressing
mTORC1). The kinase functions as part of a heterotrimeric complex
activated by Thr172 phosphorylation when AMP levels rise, creating a
molecular switch for cellular energy status.
supported_by:
- reference_id: PMID:10698692
- reference_id: PMID:11069105
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
- molecular_function:
id: GO:0047322
label: '[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity'
directly_involved_in:
- id: GO:0008203
label: cholesterol metabolic process
description: Specifically phosphorylates HMG-CoA reductase at Ser872,
inactivating the rate-limiting enzyme of cholesterol biosynthesis to
conserve cellular energy and NADPH during metabolic stress.
supported_by:
- reference_id: PMID:2369897
- reference_id: file:rat/Prkaa2/Prkaa2-deep-research-falcon.md
- molecular_function:
id: GO:0140823
label: histone H2BS36 kinase activity
directly_involved_in:
- id: GO:0006338
label: chromatin remodeling
locations:
- id: GO:0005634
label: nucleus
description: Under severe metabolic stress, phosphorylates histone H2B at
Ser36 to directly modify chromatin and activate stress-response gene
transcription, representing a direct epigenetic mechanism linking energy
status to gene expression.
supported_by:
- reference_id: GO_REF:0000024
suggested_questions:
- question: How do the α1 and α2 subunits of AMPK differ in their tissue
distribution, regulation, and substrate specificity?
- question: What determines the subcellular localization of PRKAA2-containing
AMPK complexes and how does this affect their function?
- question: How does PRKAA2 contribute to metabolic sensing and energy
homeostasis in different physiological conditions?
- question: What role does PRKAA2 play in cellular stress responses beyond its
canonical metabolic functions?
- question: Does AMPKα2's binding and stabilization of SCOT
(succinyl-CoA:3-ketoacid CoA transferase) in skeletal muscle ketone
utilization represent a broader non-catalytic scaffolding function, and
can this stabilization mechanism be confirmed in rat tissues?
suggested_experiments:
- description: Proteomics analysis to identify PRKAA2-specific substrates and
interacting partners compared to PRKAA1
- description: Live-cell imaging using FRET-based biosensors to monitor
PRKAA2-containing AMPK activity in real-time
- description: Metabolomics analysis of tissues from PRKAA2 knockout mice to
understand metabolic pathway alterations
- description: Single-cell analysis of AMPK activity and metabolic state in
different cell types using genetically encoded indicators
- description: Co-immunoprecipitation and cycloheximide-chase protein stability
assays in rat skeletal muscle to test whether AMPKα2 binds and stabilizes
SCOT (succinyl-CoA:3-ketoacid CoA transferase) and limits its
ubiquitin/proteasome-mediated degradation, probing a non-catalytic
scaffolding role in ketone utilization
status: IN_PROGRESS
📊 View Pathway Visualization Interactive pathway diagram with detailed annotations